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Abstract
The sophistication of radiation therapy delivery techniques at Mary Bird Perkins
Cancer Center (MBPCC) creates the need for an advanced dosimetric system that can
quantify and verify the dose distributions in three-dimensions. Current dosimetric systems
perform this dose analysis in only one or two dimensions.

This paper evaluates the

application of BANG-3TM polymer gel dosimetry to quantify the 3-D dose distribution of
Intensity-Modulated Radiation Therapy (IMRT) using a “step and shoot” approach. The gel
was irradiated by 10 MV photons at a dose rate of 400 MU/min. Relaxation rate maps were
computed from proton density and T2-weighted magnetic resonance images acquired with a
GE Horizon 1.5T scanner; scans were performed 5 days and 2 months post-irradiation. The
dose distribution within the gel was compared to the dose distribution calculated by the
Pinnacle3 planning system. Three techniques were used for analysis: image subtraction, dosevolume analysis and contour analysis. Also, a dose correction factor was used to attempt to
correct for excess dose delivered to the gel as the gels were erroneously placed in the
treatment room two days prior to irradiation. Corrected 5-day post-irradiation dose maps
show reasonable agreement with the Pinnacle3 plan. The absolute measurement error was +/50 cGy; however, the relative errors were large compared to the total dose of 2 Gy delivered
to the gel. Delivering a larger total dose should reduce the relative error to a reasonable
magnitude. Exposure to light and other environmental factors caused substantial additional
polymerization with time. The results of this project indicate that polymer gel dosimetry
could be a useful routine 3D dosimetric technique at MBPCC.
commercial scanning service may simplify use of the gels.

xi

However, utilizing a

Chapter 1
Gel Dosimetry
1.1

Radiation-sensitive Gels
Advancements in radiation therapy delivery techniques have presented cancer

facilities with an increased need to obtain dosimeters that can measure three-dimensional dose
distributions with good precision, accuracy and spatial resolution. Current dosimeters (e.g.,
ionization chambers, thermoluminescent dosimeters, silicon diodes and film) are effective for
dose measurements at single points, in two-dimensional planes and sometimes in threedimensions, but none offers the capability of routine three-dimensional (3D) dose
visualization. Each dosimetry technique has limitations that restrict its usefulness in
evaluating the 3D-oriented radiotherapy modalities, such as brachytherapy, intensitymodulated radiotherapy (IMRT), stereotactic radiosurgery (SRS) and charged-particle beams.
An example of these limitations is the finite size of ionization chambers, creating a difficulty
in resolving areas of high dose gradient. A second example is the difficulty of performing a
complete 3D dose measurement with film (McJury 2000). Moreover, conventional
dosimeters are not capable both of continuously measuring 3D absorbed dose distributions in
phantoms of arbitrary geometries and of integrating the dose (Novotny 2001).
Radiation-sensitive gels provide an imaging technique for measuring the 3D dose
distributions inherent in the new treatment modalities (McJury 2000). Absorbed dose causes
a chemical change within the gel that can be visualized (measured). In gel dosimetry, the
phantom itself forms the detector, which is a characteristic not shared with any other
dosimetric system. The measuring system, typically a magnetic resonance scanner, visualizes
the complete 3D dose distribution recorded in the gel (Gum 2002). Along with the 3D
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measurement capabilities, the tissue-equivalence of the gel makes this method a promising
dosimetric tool (Novotny 2001).
1.1.1 Polymer Gels and Fricke Gels
In 1984, Gore, et al., first suggested the potential of gel dosimetry in combination with
magnetic resonance imaging (MRI) as a system that can measure dose distributions in 3D.
The spin-lattice relaxation rate, R1 = 1/ T1 , was shown to have a linear correlation with the
amount of ferric ( Fe3+ ) ions produced by irradiation of a ferrous ( Fe 2+ ) solution (Haraldsson
2000). As the ferrous ions are oxidized to ferric ions, a change in the net paramagnetic
moment results, altering the spin-lattice relaxation of the water molecules near the
coordination shells of the ions (De Deene 2000). Ferric ions produce paramagnetic
enhancement of the water-proton relaxation rates, which can then be measured with MRI
(Maryanski 1994). The above process is known as Fricke gel dosimetry.
Maryanski, et al., proposed a new type of gel dosimetry system in 1993. In this
system, acrylic monomers within a gel matrix polymerize upon irradiation with an observed
relation between the degree of polymerization and the absorbed dose received by the gel
(McJury 2000). Upon irradiation of the gel, dissociation of water molecules occurs, whereby
free HO D and H D radicals are formed. These free radicals attack the double bonds of the comonomers whereby the co-monomer radicals then attack other co-monomers and form a
polymer chain (De Deene 2000). The spin-spin relaxation rate, R2 = 1/ T2 , of neighboring
water protons increases in proportion to the absorbed dose (Haraldsson 2000). Thus, MRI can
be used to visualize the absorbed dose distribution. This process is known as polymer gel
dosimetry.
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The MRI-polymerization method eliminates some problems encountered with the
Fricke-infused gels, mainly the diffusion of ferric ions, which occurs within minutes after
irradiation (Novotny 2001). The dose distribution is altered over time due to ion diffusion;
thus, there are limits to the use of the Fricke-infused gel (Haraldsson 2000). The diffusion
coefficient of Fe3+ and Fe 2+ in 1 % agarose gel at a pH of 1.1 is 2.7 ± 0.3 x 10-6 cm2s-1 and
3.3 ± 0.5 x 10-6 cm2s-1, respectively (Balcom 1995). Pederson, et al., determined that the
addition of xylenol orange to a gelatin gel reduces the ferric ion diffusion coefficient from
4.03 x 10-6 to 2.25 x 10-6 cm2s-1. Polymer gels are stable over a period of days to weeks and
can be imaged at any time during this period, resulting in greater accuracy primarily in the
regions of high dose gradient. In addition, polymer gels show insignificant radiofrequency
(RF) attenuation due to their lack of ionic species. Fricke gels, on the other hand, strongly
attenuate RF fields, producing significant variations of the RF pulse flip angle and a
decreasing signal-to-noise ratio (SNR). Both the variations of the RF pulse flip angle and the
decreasing SNR impair the accuracy of dose measurement based on MRI relaxation data
(Maryanski 1994). A greater sensitivity is obtained with the polymer gel as compared to the
Fricke gel. Drawbacks to the polymer system include a complicated mixing procedure and
the toxicity of the chemicals (Haraldsson 2000). Also, polymer gels cannot be used with
oxygen-containing materials (e.g. lung-tissue substitutes) as oxygen inhibits polymerization.
Unlike the Fricke gel, the polymer gel is not suitable as an active inhomogeneous dosimeter
(Gum 2002). Based on MRI, gel dosimetry has been shown to provide verification of
calculated dose distributions in soft tissue- equivalent homogeneous phantoms; however,
comparable results for a lung-tissue equivalent phantom have only been achieved with a
porous Fricke gel dosimeter (Oldberg 2000).
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BANGTM gel (MGS Research, Inc.), a type of polymer gel, is comprised of
N , N ′ − methylene − bis − acrylamide (BIS), acrylamide, nitrogen and gelatin. Due to its broad
stability and sensitivity, this gel offers a potential for the verification of radiotherapy dose
distributions. Radiation-induced polymerization is utilized by BANGTM-gel dosimetry
(Oldham 1998). These gels are useful for high-energy photon dosimetry as the physical and
electron densities are within 3% and 2% of water, respectively, and within 1% and 3% of
muscle (Low 1999). Like x-ray film, BANGTM gels contain a batch-to-batch variability of the
dose-response characteristics. This variability is due to the presence of gelatin, a large
naturally occurring polymer. A non-reproducible complex final structure, causing this batchto-batch variability, has been reported (McJury 2000). For this reason, it is recommended that
all gels in a given dosimetric session come from the same batch.
1.1.2

Polymerization and Dose Map Calculation

The polymer gels usually consist of an acrylamide monomer along with a crosslinking agent such as BIS uniformly dispersed in an aqueous gel (Maryanski 1994, McJury
2000, Novotny 2001). Approximately 90% of the gel is composed of water (Maryanski
1994). Irradiation-induced polymerization occurs via free radical production during water
radiolysis. The spatial dose-response characteristics of the gel originate from the
polymerization (i.e., cross-linking of regions within the gel). The amount of polymerization
depends on the quantity of free radicals generated by the absorbed radiation. The polymer
structure and concentration determine the relaxation characteristics of the gel’s water protons.
NMR relaxation rates of neighboring water protons are increased by the formation of crosslinked polymers in the irradiated regions of the gel (Novotny 2001). The transverse relaxation
rates, R2=1/T2, can be measured, allowing the dose maps to be calculated. In the range of 1-10
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Gy, R2 of the water protons in the polymerized regions, measured with MRI, is linearly related
to absorbed dose (McJury 2000). Proton density and T2-weighted MR images of an irradiated
gel can be converted to dose yielding a 3D dose map (Oldham 1998).
Unfortunately, some uncertainties in dose determination do occur. These uncertainties
are influenced by a number of factors: accuracy of the calibration curve, aging dynamics of
the polymer gel, B1-field inhomogeneity, and eddy currents (Baldock 2001). Eddy currents
occur in the cryogenic and metal casings of the MR system when magnetic field gradients are
switched; they result in spatial and time-dependent changes in the magnetic field of the
magnet (De Deene 2000). Oldham, et al., proposed a method for calculating the uncertainty
of gel dosimeters and it was concluded that the lowest uncertainty obtainable with a standard
polymerization gel is about 3 % at 8 Gy and 7% at 2 Gy (Baldock 1999).
1.1.3 Gel Preparation and Specifications
The change in R2 with dose (i.e., sensitivity) and polymer gel saturation limit are
critically dependent upon gel preparation conditions. Such conditions include oxygen and
light exposure, weight fractions of gelatin, monomer and cross-linker and temperature during
imaging. The effects of the monomer/cross-linker density are discussed in Chapter 2.2.3.
Oxygen, a free radical scavenger, inhibits gel polymerization. De-ionized distilled
water is degassed with an inert gas (e.g., pure N2) to remove any dissolved oxygen. A gelling
agent is added to this de-ionized water. Fogging of the gel can result from the bubbling of
nitrogen gas through the gel mixture, which will lead to an increased background R2 value.
Oxygen exposure is minimized by manufacturing the gel in either a sealed reaction flask or in
a sealed glove box with a nitrogen environment. Oxygen-impermeable vessels are usually
used to store the gel after it has been fabricated; glass or BAREX (BP Chemicals Inc.,
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London, UK) are common container materials (McJury 2000). Glass walls are usually thicker
than the dose build-up region for external beams. BAREX is the preferred phantom vessel
when studying dose build-up regions and dose distributions near the entrance surface of the
phantom. Furthermore, BAREX may be molded into any shape (Haraldsson 2000).
Light, like oxygen, can reduce the overall sensitivity of the gel as it can initiate
photopolymerization. Shielding must be provided once the monomer, cross-linker, and
gelatin solution have been mixed (McJury 2000). The polymer gel should be stored in a dark
area and its exposure to natural and artificial light should be minimized during use.
Irradiation of the gel dosimeter should take place soon after manufacturing due to the
potential for oxygen contamination (McJury 2000). Post-manufacture gels show a continuous
change in R2, resulting from both free radical impurities in the components of unirradiated
gels and the increasingly attenuated dynamics of the free radical reactions in irradiated gels
(McJury 1999). The optimum time to image the irradiated gel is upon reaching a steady state
with all polymerization reactions completed and maximum sensitivity having been reached.
Imaging prior to this point would result in a loss of sensitivity (McJury 1999). In the case of
the BANG-3TM polymer gel, polymerization reactions require 30 minutes to complete; in
addition, up to two days may be required to achieve equilibrium in the scanning room. To
minimize the effects of spontaneous polymerization, the gel manufacturer recommends gel
scanning within one week post-irradiation.
The sensitivity of the gel dosimeter is inversely proportional to the temperature; a
reduction in temperature during imaging will lead to larger gel sensitivity. Proton correlation
times lengthen and proton exchange rates increase as the polymer chain motion becomes
slower with a decrease in temperature. In a similar fashion, the gelatin relaxation rates also
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increase with decreasing temperature. With this in mind, prior to MRI, a gel must be allowed
to equilibrate to a uniform temperature. The temperature of the experimental gel and the
calibration gels must also be the same.
A greater visibility of the polymerized region is observed the gelatin as opposed to
agarose, both of which are gelling agents. Gelatin produces clearer gels than agarose.
Furthermore, the transverse relaxation rates of gelatin systems are approximately one order of
magnitude lower than those of the agarose gel. Sensitivity is therefore higher in the gelatin
system compared to the agarose system as the baseline R2 is decreased. Finally, a gel
consisting of 5% gelatin by weight is best because an increase in gelatin concentration causes
a decrease in both R2 and overall gel sensitivity (McJury 2000).
1.2

MRI Pulse Sequence Techniques
The spin-echo pulse sequence is a common acquisition method for MRI images.

Spin-echo methods include the single echo (Hahn spin echo) sequence and the multiple spinecho among other techniques (Baustert 2000). With the single echo technique, only a single
echo is collected by each acquisition, but the acquisition is repeated with different echo times.
The multiple spin-echo technique acquires a train of spin echoes, with different trains
acquired with different echo times (McJury 2000). To achieve optimal results in determining
T2, the multiple-spin-echo pulse sequence parameters can be varied. These parameters
include echo spacing (ES), number of echoes, and repetition time (TR) (Baldock 2001).
Baustert, et al., provided insight into an efficient method of measuring T2. Unfortunately,
multiple-spin-echo sequences available on clinical MRI scanners are generally not optimized
for determining the range of T2 values encountered in polymer gel dosimetry (Baldock 2001).
Non-optimal multiple-spin-echo acquisitions can result in errors in the R2 values owing to
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imperfect refocusing of the 180o pulses, which can lead to a standing wave effect or RF
attenuation in large aqueous samples (McJury 2000). Thus, the single echo technique is
preferred for polymer gel analysis.
1.3

Intensity-Modulated Radiation Therapy (IMRT) and Polymer Gel Dosimetry
With the advent of IMRT techniques, the validation of dose distributions produced by

planning systems is required from the radiation physicist. Intricately shaped conformal dose
distributions, particularly with concavities and steep dose gradients between the boundaries of
the planning target volume (PTV) and the organ-at-risk (OAR) in all three dimensions, are
characteristic of IMRT (Oldham 1998). Through IMRT, a conformal irradiation is achieved
by delivering beams composed of different beam segments to the patient (De Deene 2000).
With complex (e.g., concave-shaped) PTVs, IMRT is the major hope for achieving the
maximum protection of the OAR with the best possible tumor control probability (TCP)
without an increase of normal tissue complication probability (NTCP) (Gum 2002).
Treatment planning for IMRT must have high spatial accuracy to ensure adequate coverage of
the PTV and sparing of the OARs in the presence of the highly conformal distributions.
According to Oldham, et al., there is much research effort aimed at measuring IMRT
distributions in 3D and comparing these to the planned distributions.
For successful clinical implementation of IMRT, a dosimetric verification process
must be established to ensure that the delivered doses are consistent with the calculated doses
for each patient. There are generally three types of measurements that can be used to provide
dose verification (Zhu 2002):
1) an absolute measurement using calibrated detectors such as ion chambers
2) relative 2-D dose distribution measurements using radiographic or radiochromic
film; relative 3-D measurements with polymer gels
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3) the use of charge-coupled device (CCD) imaging, electronic portal imaging
devices (EPID) or radiographic films to verify the projected fluence pattern
perpendicular to the incident beam
Clinical IMRT distributions are commonly verified in a two-step process. Positional accuracy
of the high-dose regions and gradients is confirmed by film measurement followed by a
quantitative diode or ion chamber measurement to verify the absolute dose at the reference
point in the distribution. Gel dosimetry provides potentially both results with a single
measurement, making it attractive for the verification of IMRT (Oldham 1998).
1.4

Project Objective
The objective of this study is to evaluate the application of BANG-3TM gel

dosimetry to quantify the 3D dose distribution of IMRT with a “step and shoot” approach
delivered by the Varian Clinac 21EX. This dose distribution will then be compared to the
predicted static tomotherapy dose distribution calculated by the Pinnacle3 planning system. In
this plan, the target volume will be the prostate, while the organs at risk will include the
bladder, rectum and femoral heads. This comparison will provide the staff at Mary Bird
Perkins Cancer Center (MBPCC) some insight into the effectiveness of using the BANG-3TM
gel as a verification tool for IMRT treatments. Also, this study will provide MBPCC’s staff a
recipe for the future use of this dosimetric system and some understanding into the feasibility
and limitations of its use.
Calibration of the dosimeter is done at the time of use for each gel batch. To calibrate,
a range of known doses is applied to a portion of the gel batch. The calibration is done in a
water-filled calibration phantom; with the use of MRI, a plot of R2 (s-1) versus known dose
(Gy) can be obtained (McJury 2000).
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The MRI scanner produces the 3D gel image in the form of T2 –weighted and protondensity-weighted images that are combined to compute the relaxation rate (R2). A conversion
of the image to absorbed dose must occur to allow verification of radiotherapy dose
distributions (Oldham 1998). Dose distributions are imaged in multiple planes with the gel
dosimetry system. Dose maps obtained from the polymer gel are compared to the Pinnacle3
dose plan pixel by pixel using a commercial data-processing package. Comparisons are done
by image subtraction, by direct comparison of isodose curves and by dose volume analysis.
The desired accuracy is about 5% relative to the maximum dose deliverable to the gel
(approximately 10 Gy).
1.5

Conclusion
Polymer gel dosimetry for measuring 3D dose distributions is promising but may not

yet be clinically practical. Numerous questions related to the methods and cost remain. Gel
phantoms for IMRT dose mapping currently cost $350 each and $250 each for SRS dose
mapping. Additional materials (e.g., calibration vessels, MRI system access and fiducial
markers for reproducible positioning of the phantom) are necessary to conduct research and
plan verifications. The gels can be self-manufactured, but along with material costs, safety is a
concern because the components of polymer gels are extremely toxic.
Fortunately, research is underway to better understand this dosimetry system and
interest in the development and application of the polymer gel dosimetry technique is
growing. In 1999, the first international workshop dedicated to gel dosimetry (DOSGEL’99)
took place, followed two years later by the second international workshop (DOSGEL’01).
Due to this increased research and recent interest, the polymer gels may be realistically
available for widespread clinical use within a couple of years. Ideally, greater demand for the
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gel should lower the cost. With the advent of IMRT and SRS, the increased use of high-doserate sources at MBPCC and the potential benefits of polymer gel dosimetry, an evaluation of
the effectiveness of the BANG-3TM gel system for IMRT verification should be beneficial to
MBPCC.
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Chapter 2
Literature Review
2.1

Historical Overview
2.1.1 Introduction
Radiation-sensitive gels were first developed in the 1950s when Day and Stein

investigated a color change upon irradiation of a gel containing Folin’s phenol. In 1957,
Andrews, et al., made measurements of photon and electron depth doses using agar gels.
Later studies were done which utilized Fricke solutions and gels, and in 1958, Hoecker and
Watkins studied an alternative method. This method was based on radiation-induced
polymerization in monomer and polymer solutions (McJury 2000).
Several studies investigated the use of Fricke gel dosimeters. Gum, et al., determined
that an inhomogeneous anthropormorphic Fricke gel phantom and 3D magnetic resonance
imaging are valuable tools for verification of IMRT treatment plans. The phantom was that of
the human thorax including the lungs and spine, where the thorax and spinal cord consisted of
undiluted Fricke gel and the lungs were filled with low-density Fricke gel. An average
deviation of less than 5% between measurement and planning was found in regions containing
the standard Fricke gel, whereas a higher deviation was found in regions consisting of the
low-density gel. The greatest error was due to decreased SNR in the magnetic resonance
measurement for the low-density gel. Oldberg, et al., demonstrated that Fe2+-infused lowdensity gel was suitable for measurements of absorbed dose distributions in phantoms
containing lung tissue compartments. In this study, a low-density dosimeter gel and a
conventional ferrous sulphate gel were filled in separate compartments of a Perspex container.
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Chu, et al., conducted a study on two new Fricke dosimeter gel systems with low Fe3+
diffusion. These two systems, polyvinyl alcohol-Fricke hydrogel and cryogel, have been
developed for 3D radiation dosimetry purposes. Because of its optical transparence, the
hydrogel can be imaged by either optical or MRI detection methods. On the other hand, the
cryogel is opague, so the internal Fe3+ concentration can only be measured by MRI.
2.1.2

Polymer Gel Dosimetry

The BANANA gel (composed of BIS, acrylamide, nitrous oxide, and agarose) was the
first polymer gel. In this type of gel, acrylamide and BIS were added to a simple agarose gel.
Future work involved the use of polyacrylamide gels (PAG) and BANGTM gels. BANGTM
gels were produced to provide the gel solution with a greater sensitivity. Nitrous oxide and
nitrogen are added to the gel mixture to displace oxygen from the gel during manufacture
(McJury 2000). BANG-1TM and BANG-2TM gels are current models of BANGTM gels. The
former is made using acrylamide in powder form, while the latter replaces acrylamide with
acrylic acid and NaOH to buffer the pH. Gel response is improved with acrylic acid
compared to acrylamide, allowing larger relaxation-rate changes per unit dose. Acrylamide is
a neurotoxin that can lead to nervous system disorders. Safe handling of acrylamide is
essential and appropriate care should be taken when disposing of the gel. (McJury 2000).
BANG-3TM gels have recently been developed. This type of gel has strong optical and
MR responses (Oldham 2001). With the BANG-3TM gel, acrylic acid is replaced with
methacrylic acid. Table 2.1 summarizes the gel types and compositions. Of the BANGTM
polymer gels, BANG-3TM polymer gel reportedly has the highest MR sensitivity upon photon
irradiation (Ramm 2000).
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Table 2.1. Polymer Gel Types and Compositions
Type
Composition
BANANA
BIS, acrylamide, nitrous oxide and agarose
BANG-1TM
BIS, acrylamide, nitrogen and gelatin
TM
BANG-2
BIS, acrylic acid, sodium hydroxide, nitrogen and gelatin
BANG-3TM
BIS, methacrylic acid, sodium hydroxide, nitrogen and gelatin
2.2

Gel Response Studies
2.2.1 Introduction
To use the polymer gel dosimeter in a clinical setting, the response of the

dosimeter to different physical conditions must be known. Such physical conditions include:
polymer-gel composition, temperature during irradiation and NMR evaluation, type and
energy of radiation, dose rate dependence, time from irradiation to NMR evaluation (Chapter
1.1.3) and magnetic field strength. These different conditions can potentially affect
polymer gel dosimeter response, thereby significantly influencing the measured results
(Novotny 2001).
2.2.2

Temperature Effects

Temperature effects have been evaluated on polymer gels. The dose response of
BANGTM reportedly shows little dependence on the temperature during irradiation, but does
depend upon the temperature during imaging (Maryanski 1994). A temperature rise of 1-3 ˚C
is not uncommon during imaging due to RF power absorption by the gel dosimeter. A
temperature rise of 3 ˚C results in a dose underestimation of 10% over the whole dose map
(De Deene 2001). Salomons, et al., reported that the temperature during irradiation is a very
important parameter requiring control and that temperature change effects on gel performance
are important issues that require further study. They argue that polymerization reaction rates
within the dosimeter are affected by temperature changes and that the size and shape of the

14

gel dosimeters along with their environment during and after irradiation are factors that
should be controlled to ensure reproducibility.
2.2.3

Weight Fraction Variation

A study involving the variation of both the absolute and relative weight fractions of
monomer and cross-linking agents was performed by McJury, et al., in 2000. They reported
that expanding the total monomer content of the gel from 3% to 6% increases the sensitivity
and the dose saturation point of the gel dosimeter. A limit to the concentration of comonomers is set by the low solubility of BIS, as well as by crystallization during storage of
high co-monomer content gels. Also, McJury reported that peak sensitivity is obtained for
equal amounts of cross-linker and monomer content, while the dose saturation point continues
to rise for increasing cross-linker fraction. With an increase in the cross-linker fraction, the
monomer-to-polymer conversion per unit dose decreases; there is a lower reactivity of the BIS
cross-linker to the acrylamide. However, there is increased rigidity of the polymerized gel as
the cross-linker density increases. The greater rigidity allows efficient spin diffusion,
decreasing the motional averaging due to dipolar interactions. This, in turn, causes the R2 of
the gel to rise (McJury 2000).
2.2.4 Energy and Dose Rate Dependence
To date, only two studies have been reported that evaluate energy and dose rate
dependence for the BANG-2TM polymer gel dosimeter (Maryanski, et al. and Novotny, et al.)
Maryanski, et al., compared diode measurements in water to central axis percentage depth
dose measured in a gel dosimeter for 6 MV X-rays and 15 MeV electron beams. They
concluded that there is no energy or dose rate dependence of the gel dosimeter response in the
range of 2-15 MeV and dose rates in the range of 20-400 cGy·min-1.
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Novotny, et al., studied dosimeter sensitivity dependence on photon energy using 4,
16, and 18 MV X-rays from the Varian Clinac 600C and 2100C. For electron beams, 9, 12,
16, and 20 MeV beams were produced by a Varian Clinac 2100C, while the same machine
was used to measure the dose rate dependence with repetition rates of 80, 160, 240, 320, and
400 MU min-1. This study concluded that polymer-gel dosimeter sensitivity decreases with
increasing photon or electron energy; however, no clear trend was observed for sensitivity
dependence on dose rate. Several studies measuring the energy and dose rate dependence of
the BANG-1TM polymer gels have been reported (Novotny 2001), but no studies of these
effects on the BANG-3TM polymer gel have been published. Polymerization is independent of
dose rate in the BANG-1TM gel (Ramm 2000), and the response is independent of energy and
type of radiation (Novotny 2001).
2.2.5

Other Response Effects: Magnetic Field Strength, pH Studies and
Gel Aging

In a study performed by Haraldsson, et al., both the slope of the dose-response curve
and intercept were found to decrease with increasing magnetic field strength. During a study
in 1993, an opposite relationship was found by Maryanski, et al. Differences between the
results can be attributed to different gel types and different temperatures during evaluation
(Haraldsson 2000). Other investigations of the polymer gel dosimeters include pH studies
(Gochberg 1998) and studies on the effects of gel aging on image quality (McJury 1999).
McJury, et al., report a continuous change in R2 for post-manufacture gel (irradiated and
unirradiated). For the unirradiated gel, this change in relaxivity is due to the initiation of
polymerization by the presence of free radical impurities, whereas for the irradiated gel, the
relaxivity change can be attributed to the increasingly attenuated dynamics of the free radical
reactions as the viscosity of the gel increases with increasing polymer density.

16

2.3

Imaging of Polymer Gels
2.3.1 Magnetic Resonance Imaging
Two methods for imaging the spatially localized polymerization are MRI, as discussed

in Chapter 1.1.2, and optical scanning methods (McJury 2000). In an MRI scanner, relaxation
time constants (T1 and T2) are measured by applying a radiofrequency (RF) pulse to excite the
magnetization of the spin system followed by sampling during the return to equilibrium
(McJury 2000). With the Fricke gel dosimeter, maps of the T1 relaxation parameter can be
obtained (Oldham 2001). Using the polymer gel dosimeter, T2 can be measured by fitting the
collected data from at least two points on the transverse relaxation curve (McJury 2000).
2.3.2 Optical Imaging
Much research effort is being conducted into developing alternative methods to image
the dose distribution recorded in gel dosimeters (Oldham 2001). New techniques are being
investigated to find imaging techniques with less inherent noise than MRI and to eliminate
reliance on MR technology with its associated issues of limited access and high scanning cost
(Oldham 2001). Polymer gels can be easily visualized upon irradiation due to their opalescent
appearance as the radiation dose increases. Qualitative testing can thus be done by visual
inspection or through the use of an optical densitometer (Maryanski 1994). Oldham, et al.,
performed a study on the effectiveness of gel dosimetry and optical-CT (computerized
tomography) scanning as a verification method for complex radiosurgery deliveries and by
extension IMRT deliveries. As the laser was stepped in increments of 1 mm across the flask,
horizontal line scans were taken. A total of 100 projections were acquired which
corresponded to 180 degrees of projection data. A RTAP (Resolution-Time-AccuracyPrecision) criteria of ≤ 1mm3 resolution, less than 1 hour imaging time, within 3 % accuracy
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and less than 1 % precision was applied. The paper demonstrated that the optical-CT
scanning method for BANG-3TM gels yielded maps of sufficient accuracy, resolution, and
precision and approached a major goal of dosimetry.
McJury, et al., performed an investigation that utilized optical scanning as an imaging
technique. Due to the increase in opacity of the gel upon irradiation, they determined that it is
possible to use the optical scanning technique to generate a two-dimensional dose distribution.
Light attenuation was found to be related to polymer density and thus absorbed dose, with the
understanding that light within a BANG-1™ gel is scattered rather than absorbed by the
polymer particles. McJury, et al., noted that the attenuation coefficient for 500 nm
wavelength light increased by about 0.7 mm-1 with a dose increase of 0 Gy to 5 Gy using a gel
sample irradiated with a series of uniform dose regions. Moreover, the attenuation was found
to be directly related to absorbed dose over the dose range from 0-10 Gy. It was concluded
that from the preliminary optical scanning studies the optical scanning technique could either
replace or at least supplement the NMR imaging method of dose measurement (McJury
2000).
2.3.3 X-ray Computed Tomography
Several studies have been conducted using X-ray computed tomography (CT) as a
means to image the polymer gel (Audet 2002, Hilts 2000, Trapp 2001). In Audet’s study, two
polyacrylamide gels (PAGs) of different compositions were irradiated with a four-arc
stereotactic treatment to maximum doses of 15 Gy and 8 Gy, respectively. Image averaging
and background subtraction of the CT images were used to improve the image quality.
Conversion of the PAG images to relative dose maps used a CT number-dose calibration
curve to allow for comparison to the planned isodose distribution. Registration of the PAG
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images to the planning CT images was reported to show good agreement. Investigation of
more complex dose distributions and improvement of dose resolution are future studies of this
group (Audet 2002).
Hilts, et al., also studied the use of X-ray CT as a method to analyze polymer gels.
The experiment involved used two 1.5 L cylindrical polymer gel phantoms composed of 3%
acrylamide, 3% BIS and 5% gelatin by weight. One phantom was irradiated with four
intersecting 10 MV photon beams whereas the second phantom was irradiated with 10 sets of
parallel-opposed radiosurgery fields. In addition to developing an imaging protocol to
optimize the CT images of polymer gels, the group investigated the relationship of polymer
gel CT number to dose (NCT-dose response), determined the reproducibility of the response
and compared CT to MRI to analyze the polymer gels. An optimized imaging protocol is
necessary due to the fact that CT imaging is sensitive to radiation induced density changes
that occur within the polymer gel. The group concluded that the NCT-dose response is not
only reproducible and linear up to 8-10 Gy, but is also relatively insensitive to the gel
temperature during imaging. They note a downfall of this imaging method is the poor dose
resolution of approximately 50 cGy for a slice thickness of 10 mm; MRI has a dose resolution
of about 20 cGy for a slice thickness of 5 mm, but is very sensitive to gel temperature during
imaging. The group concluded that CT imaging technique has three major disadvantages
compared to MRI: lower dose sensitivity, greater dose uncertainty and the post irradiation
wait prior to imaging (waited one week before CT imaging to prevent the gel from responding
to dose from the CT scanner). Despite these downfalls, the CT polymer dosimetry technique
appeared to be accurate and capable of localizing high dose gradients (Hilts 2000).
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Trapp, et al., investigated the effects of the composition of the polymer gel dosimeters
on the CT-dose sensitivity. This group studied several gel compositions, comparing
acrylamide to BIS comonomers and comparing agarose to gelatin gelling agents. An increase
in comonomer concentration was found to increase the CT-dose sensitivity. Also, the use of
agarose instead of gelatin increased the sensitivity. Dose resolution was found to be optimal
for a polymer gel dosimeter composition of 5% gelatin, 3% acrylamide, 3% BIS and 89 %
water was reported (Trapp 2001).
2.3.4

Fourier-Transform Raman Spectroscopy

Fourier transform (FT)-Raman spectroscopy studies have been perfumed on
polyacrylamide gels (Baldock 1998, Jirasek 2001). Baldock, et al., investigated cross-linking
changes during the copolymerization of PAGs in the spectral range of 200-3500 cm-1. The
vibrational bands of the single binding modes of acrylamide and bis-acrylamide were found to
decrease in amplitude with increasing absorbed radiation dose. They concluded that FTRaman spectroscopy has potential for ionizing radiation dosimetry using PAGs (Baldock
1998).
The study by Jirasek, et al., utilized FT-Raman spectroscopy to characterize the rates
of monomer and crosslinker consumption and polymer formation. The consumption
rates of monomer and crosslinker were characterized in the spectra as a function of absorbed
dose and were found to be monoexponential up to 13 Gy. The rates of consumption are
different for the two molecules, with a higher rate of consumption found for BIS compared to
acrylamide. Polymer formation, up to a dose of 13 Gy, was monoexponential and correlated
well with the consumption rate of acrylamide. Like the previous study, these results indicate
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that Raman spectroscopy provides a direct and useful tool for characterizing an irradiated
PAG.
2.3.5

Ultrasound Imaging

One study involving the use of ultrasound to evaluate a polymer gel has been reported.
Mather, et al., investigated this method for evaluating radiotherapy 3D polymer gel
dosimeters. The method involves the use of ultrasound to evaluate the important structural
changes that occur following dosimeter irradiation. Acoustic speed of propagation,
attenuation and transmitted intensity were measured as a function of absorbed radiation dose.
Each parameter showed a strong variation with absorbed dose continuing beyond absorbed
doses of 15 Gy. Also, a larger dynamic range in the dose response curves was found with the
ultrasonic measurements as compared with MRI dose response data previously published.
The group concluded that the ultrasound technique shows great potential for the evaluation of
polymer gel dosimeters (Mather 2002).
2.4

Radiotherapy Applications for Polymer Gels
2.4.1 Intensity-Modulated Radiation Therapy (IMRT)
Research effort is aimed at measuring IMRT distributions in 3D and comparing the

measured to the planned distributions (Oldham 1998). In a study performed by Oldham, et al.,
it was concluded that gel-measured distributions compared well with plans from a Peacock
planning system using an in-house dose algorithm. Two irradiation experiments were
conducted with a homemade BANG-gel dosimeter. The two distributions were that a
parallel-opposed irradiation and a nine-field “static tomotherapy” intensity-modulated
irradiation delivered with a Nomos MIMiC. They concluded that the gel dosimeter agreed
well with the predicted dose distributions and the steep penumbral fall-off of the dose was
reproduced very accurately. At medium to high doses (50-90% isodose lines), the predicted
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distribution agreed well with the gel-measured distribution. Differences of up to 10% were
found at lower doses (30% isodose line). For doses greater than 50%, isodoses were in
general agreement to 1 mm with a maximum discrepancy of 3 mm.
2.4.2 Stereotactic Radiosurgery and Radiotherapy
Investigations of polymer gel dosimetry for stereotactic radiosurgery include
comparison of a planned and measured 3D stereotactic dose volume (Audet 2002), image
distortion in MRI-based polymer gel dosimetry of gamma knife stereotactic radiosurgery
stystems (Watanabe 2002) and reproducibility of polyacrylamide gel (PAG) dosimetry
applied to stereotactic conformal radiotherapy (Cosgrove 2000). The study performed by
Audet’s group was previously discussed (Chapter 2.3.3), whereby the high dose region
produced by the stereotactic treatment was accurately localized by the CT gel technique.
Watanabe, et al., investigated the effects of collimator size and MR image distortion
on polymer gel dosimetry of gamma knife stereotactic radiosurgery systems. Both CT scans
and magnetic resonance images of the BANG™ polymer gel were acquired and directional
frequency encoding and receiver bandwidth artifacts in the images were studied. An image
shift of the measured dose distributions of two pixels was observed in the frequency encoding
direction for both MRI and CT. The results were found to be reproducible and independent of
collimator size and the observed shifts were said to be caused by MR image distortion due to
magnetic susceptibility effects.
Cosgrove, et al., tested the reproducibility of polyacrylamide gel dosimeters for a
three-field coplanar arrangement and a four-field, conformal, non-coplanar plan using
precision-cast lead alloy shielding blocks. The three-field plan used linac jaws for field
shaping. Reproducible relative dose distributions were encountered with a standard deviation
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on the mean areas enclosed by the 50% isodose lines, measured in three orthogonal planes of
6.4% and 4.1% for the coplanar and non-coplanar plans, respectively. The group also found
consistency between the measured and planned distributions. Isodose lines agreed generally
to within a few millimeters; however, the measured absolute doses were, on average, 23.5%
higher than those planned.
2.4.3 Carbon Ion Therapy
Ramm, et al., studied the application of three-dimensional BANGTM gel dosimetry to
carbon ion therapy. The BANGTM polymer gel dosimeters were visualized by MRI. Their
objective was to examine saturation effects for densely-ionizing (high linear energy transfer
(LET)) radiation. The gels were irradiated with monoenergetic 12C ions at different beam
energies. Results demonstrated that BANGTM gel dosimetry with MRI could be used for
conformal heavy-ion radiotherapy. Measurements of target volume contours and dose
gradients can be obtained with high spatial resolution. Furthermore, the influence of LET on
saturation effects and the importance of the microscopic dose pattern for high-LET radiation
were demonstrated (Ramm 2000).
2.4.4

Brachytherapy

Farajollahi, et al., investigated the use of polymer gel dosimetry in low dose rate
brachytherapy. The response of gel was found to be reproducible and linear up to 10 Gy.
Measurements of the absorbed dose distributions for a straight applicator containing 36 137Cs
sources measured with the gel and TLDs were compared to the calculated values. A good
agreement for relative measurements was found. Additionally, measurements for a complex
gynecological insert were compared with the isodose curves from a Helax TMS planning
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system. Within areas unaffected by oxygen diffusion, an agreement within 0.5 mm was found
for the 50-100% isodose levels (Farajollahi 1999).
McJury, et al., investigated the 3D dosimetry of a high-dose-rate clinical 192Ir source
to avoid errors imminent in the dosimetry of a brachytherapy source. Experimental dosimetry
measurements can be inaccurate for several reasons: poor spatial resolution for ion chambers,
lack of 3D information using film and errors due to distortion of the radiation flux by the
dosimeter itself. The group compared experimental measurements of the dose versus radial
distance from the center of the source to calculations from a Nucletron planning system
(NPS). In the selected planes, a good agreement was found between the planning system and
the gel measurement. The group concluded that polymer gel dosimetry shows promise for
brachytherapy applications and can offer complete 3-D dose information, good spatial
resolution and small measurement errors. However, measurements close to the source were
difficult to acquire due to limiting properties of the polymer gel (i.e., saturation of gel)
composition at around 10 Gy and oxygen diffusion at surface of catheter (McJury 1999).
2.4.5 Boron Neutron Capture Therapy
Two groups are studying the use of polymer gel dosimetry in boron neutron capture
therapy (BNCT), a tumor specific treatment modality, (Farajollahi 2000 and Wojnecki 2001).
Farajollahi, et al., exposed polymer gels with and without 60 ppm of 10B to an epithermal
neutron beam. The gels were irradiated in vials in pairs in a water phantom for 5 hours each.
The variation of relaxation rates of the gels with depth were measured and compared to
MCNP Monte Carlo calculations. Boron enhanced absorbed dose in the gel measurements.
The group concluded that polymer gels could measure the enhancement of absorbed dose due
to boron for epithermal or thermal neutrons (Farajollahi 2000).
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Wojnecki, et al., performed a computational study on the use of polyacrylamide gel
and A-150 plastic as substitutes for brain tissue in BNCT. Using a phantom material that
closely resembles brain tissue is a necessity to precisely evaluate the dosimetric performance
of epithermal neutron beams designed for BNCT of brain tumors. The study compared the
performances of polyacrylamide gel and A-150 plastic to standard phantom materials such as
water and polymethyl-methacrylate (PMMA) as substitutes for brain tissue. The group
concluded that the polyacrylamide gel is promising for the use with BNCT as it provides a
good simulation of the radiation dose components in brain tissue. The polyacrylamide gel can
be used as both a phantom material and a dosimeter. Also, A-150 was found to provide a
better simulation of the radiation transport in the brain tissue than PMMA and thus should be
used as a solid phantom material. It was determined that water also is a suitable phantom
material for BNCT. However, further research is required into calibration of the MR-derived
dose images (Wojnecki 2001).
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Chapter 3
Materials and Methods
A summary of the necessary equipment, their functions and the measurements and
analysis to be carried out in this project are discussed in this section. The ultimate goal of this
project is to provide guidance to MBPCC in using polymer gels to verify 3D IMRT treatment
plans from the Pinnacle3 planning system.
3.1

Equipment Overview
3.1.1 Introduction
The BANG-3TM polymer gels require a complicated mixing procedure and some of the

chemicals within the gel (e.g., acrylamide, BIS) are toxic, thus this project utilizes premanufactured gels (MGS Research, Inc.). Other equipment which is used include: the
Pinnacle3 treatment planning system, the Varian Clinac 21EX, an MRI scanner, an ionization
chamber, an electrometer, the RIT system, XV film and solid water (Table 3.1).
3.1.2 In-house Equipment
Several pieces of equipment necessary for this project are available at MBPCC. The
Pinnacle3 treatment planning system is the system currently used at MBPCC. Conventional
therapy plans have been done with this system for several years, but recently the workload has
risen tremendously due to the advent of IMRT therapies. Currently, IMRT plans are
generated by the Pinnacle3 treatment planning system for prostate cancers, head and neck
cancers, lung cancers and brain cancers. Eventually, the Pinnacle3 system will be used to plan
IMRT treatments for breast cancers. The cubical water phantom, ionization chamber,
electrometer, RIT system, XV film and solid water are all easily accessible at MBPCC. The
MRI scanner is available at Our Lady of the Lake Regional Medical Center (OLOLRMC).
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Table 3.1 Equipment utilized in study, quantity and supplier of materials and total cost.
Equipment
Quantity
Supplied By
Cost ($)
VIAL
9
MGS Research, Inc.
270
CGEL-S
1
MGS Research, Inc.
340
SCM set
1
MGS Research, Inc.
25
Varian Clinac 21 EX
N/A
In House
0
3
Pinnacle Planning
N/A
In House
0
Computer
MRI Scanner
N/A
OLOL Regional
0
(GE Horizon 1.5T)
Medical Center
N/A
In House
0
RIT 113 Film
Dosimetry system
Version 3.11
1
In House
0
ionization chamber
(PTW 30006 – SN
0419)
In House
0
ionization chamber
(N-243342-868)
parallel plate
1
In House
0
Electrometer A
(MK 614 – SN
312275)
Electrometer B (K
1
In House
0
602-SN 390556)
MEDTEC phantom
1
In House
0
XV film
10
In House
0
Solid water
2 5-cm slabs
In House
0
Shipping, Packing,
N/A
N/A
30
and Handling
3.1.3 BANG-3TM Polymer Gel
The BANG-3TM polymer gel used in this experiment has a maximum measurable
dose of 10 Gy. Technical specifications are listed in Table 3.2. The maximum measurable
dose is set by the amount of reducing agents added to the gel (Maryanski presentation).
Gaseous oxygen contamination strongly affects the dose response of BANGTM gels. The gels
are therefore made under anoxic conditions and must be hermetically sealed at all times.
Ultraviolet light and blue light induce photo-polymerization of monomers in the BANGTM
gels. Exposure to daylight and fluorescent light should be minimized (MGS Research Inc.
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Table 3.2 Technical specifications for the BANG3™-polymer gel. Adapted from MGS
Research, Inc. website.
Technical Specifications
Maximum Dose:
variable
Maximum Dose Rate:
4 Gy/minute
Accuracy:
+/- 3% at 3 Gy
Specific gravity:
1.05 g/cc
Atomic composition (weight fractions):
C: 0.1045 O: 0.7668 N: 0.0244 H: 0.1042
Dose response is independent of photon or electron energy. Spatial resolution is limited by
MRI voxel size.
website). Irradiation should occur no more than two weeks from shipment. MGS Research,
Inc., the manufacturer of BANG-3TM polymer gel, asserts that the dose response of the gel is
independent of photon or electron energy. No other data analyzing the relation of the dose
response to the photon or electron energy are available. Likewise, no data have been reported
on the dependence of dose-response of the BANG-3TM polymer gel on dose rate. Several
studies are available on the BANG-1TM and BANG-2TM polymer gels; almost all of them
conclude that the dose-response is independent of dose rate.
3.1.4 IMRT at MBPCC
At MBPCC, treatment using IMRT is currently done with two Varian Clinac 21EX
systems, one in Baton Rouge and the other in Covington. Both accelerators are equipped with
multi-leaf collimators (MLCs) to achieve a conformal dose distribution. Photon energies of 4
and 10 MV are available for treatments with the Baton Rouge machine, while the accelerator
in Covington provides photon energies of 6 and 18 MV. IMRT treatments are achieved with
MLCs because the computer-driven multileaf collimators modulate the incident radiation
fluence as a function of gantry angle and off-axis distance (Low 1998). In particular, a “step
and shoot” approach is used by MBPCC, whereby the dose distribution is delivered with the
MLCs immobile during each irradiation. IMRT was designed in an effort to maximize the
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dose to the planning target volume (PTV) while sparing the organ(s)-at-risk. MBPCC uses
photon beams to execute the IMRT treatments. Dose rates commonly used for these
treatments are 250

MU
MU
for the 4 MV photon beams and 500
for the 10 MV photon
min
min

beams.
3.1.5 Gel Calibration
For calibration, a quantity of the gel is contained in borosilicate glass vials (VIAL)
with dimensions of 25 mm OD, 95 mm length, 1.3 mm thick wall, and a 1 mm thick bottom.
The vials are positioned parallel to the radiation beam in a cubic water phantom with the
water filled to at least 10 cm above the vial surface (see Figure 3.1). Each vial receives a
different total dose to obtain a calibration curve, which relates the dependence of the
transverse relaxation rate,1/ T2 , to absorbed dose.
3.1.6 Dose Mapping
For purposes of dose mapping of the IMRT treatment field, BANG-3TM polymer gel
fills a BAREX plastic cylinder (CGEL-S) with phantom dimensions of approximately 2L
volume, 17 cm OD, and 10 cm height. The CGEL-S is irradiated with a simulated IMRT plan
obtained from Pinnacle3 using 10 MV photon beams. The treatment plan is detailed in
Appendix A. The Varian Clinac 21 EX with a dose rate of 400

as 4

MU
is utilized in this study
min

Gy
is the maximum allowable dose rate with this gel (Table 3.2).
min

3.1.7 Imaging of the Polymer Gel
MRI is used at OLOLRMC as a means of obtaining high quality images of the internal
anatomy of the human body. The method is based on principles of nuclear magnetic
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Figure 3.1 Calibration vial procedure set-up. Figure shows calibration vial positioned on the
bottom of the MED-TEC water phantom with approximately 10 cm water above the vial. The
gantry was positioned at 0˚ with the vial irradiated from the bottom up. Within the vial is the
BANG-3TM gel.
resonance to obtain microscopic chemical and physical molecular information (Hornak
website, Webb 1988). A radio-frequency pulse to excite the magnetization of the spin system
is applied followed by sampling during return to equilibrium. The sampling allows for the
relaxation times (T1 and T2) to be measured (McJury 2000). Currently, the MRI scanner at
OLOLRMC is utilized by MBPCC during MRI/CT fusion for stereotactic radiosurgery (SRS).
With polymer gel dosimetry, the MRI scanner can also be used to obtain images of the 3-D
dose distribution.
3.1.8 Experimental Procedure
A 3D distribution of absorbed dose within the polymer gel is fixed upon irradiation.
Upon receiving the gels, they are stored in a room with temperature between 18-23 ˚C, away
from sunlight and fluorescent light. A few days after gel acquisition, an initial MRI scan is
taken of the CGEL-S phantom and gel vials providing background measurements of the gel.
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CT scans of the BANG-3TM gel phantom are then obtained to develop a plan on the
ADAC treatment planning system. Five fiducial markers are placed on the CGEL-S phantom
to facilitate repositioning between irradiations and imaging (e.g. shifting and rotation). In
addition, crosshairs are marked on the outside of the CGEL-S. CT scans deliver less than 5
cGy of dose, which is less than 0.5% of the maximum deliverable dose (10 Gy) (Maryanski
email) and 2.5% of the actual 2 Gy delivered. After the CT scan, a second MRI scan is taken
of the CGEL-S phantom to measure any dose from the CT scan or photo-polymerization.
This scan is also used for background subtraction of the polymer gel within the phantom.
The phantom is mounted on the treatment couch and irradiated according to the
treatment plan. This treated volume simulates a prostate treated with a seven-field IMRT
plan. MRI scans of the irradiated BANG-3TM are then taken. Calibration gels are also
irradiated and scanned by the MRI scanner. The R2 (relaxation rate) maps calculated from
the images are used with the calibration data to acquire quantitative dose maps. Spatial
visualization of the treatment volume is obtained from T2 -weighted images of the irradiated
BANG-3TM gel.
A fourth imaging session some time after irradiation is used to test the stability of the
polymer gel. These images are taken approximately two months after the gel irradiation and
provide some insight as to how the polymerized regions change over time. These results
provide a timetable into when the polymer gels should be imaged and whether or not imaging
sessions at a later time would be accurate or beneficial.
The dose determined from the polymer gel is compared to an IMRT QA procedure
using solid water and XV film for independent verification. Also, an ionization chamber is
used to measure the absolute dose at isocenter. All three procedures are compared with the
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planned dose distributions from the Pinnacle3 system whereby the three techniques are
evaluated.
Finally, all data analysis involving the polymer gel dosimeter is done via the IDL
computer software. IDL provides a wide range of procedures, including aligning data with
one another so that it can be accurately compared. This analysis software also has excellent
graphing capabilities that provide the experimenter with a means to display figures.
3.2

Dose Verification
3.2.1 Introduction
A comparison is made between the calculated dose from the Pinnacle3 system and the

dose within the polymer gel, as measured by MRI. To further verify the gel dosimetry results,
additional measurements are made with conventional dosimeters. An ionization chamber
(correction factor = 5.362 x 107 Gy/C) and electrometer are used to measure the dose within
the cubic water phantom where the vials are irradiated. XV film, solid water and the RIT
system are used to determine the 2D distribution delivered by the beams at a source-to-axis
distance (SAD) of 100 cm. Also, the ionization chamber and electrometer are used to
measure dose at isocenter within the solid water.
3.2.2 Calibration Vials
For calibration purposes, eight vials are placed on the bottom of the water tank at the
delivered to each vial in order to obtain a calibration curve for the 4 MV and 10 MV photon
beams. These doses ranged from 1 Gy to 9 Gy. To ensure that these doses are properly
delivered to the vials, an ionization chamber is used to determine the dose at d max , the
location used to obtain the calibration curves.
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As the cubic water phantom contains 1 cm of acrylic at the bottom, a correction factor
is computed to determine the effects of the acrylic on the beam energy. To obtain a correction
factor, three measurements with the ionization chamber (PTW-30006) are taken with
electrometer A with the chamber positioned 10.36 cm below the water surface and the gantry
rotated to180°. The three measurements are then averaged. Three additional measurements
are taken and averaged at a gantry angle of 0° with the ion chamber positioned 10.36 cm
above the bottom of the tank. This depth was chosen due to an inability of the ion chamber to
be placed at a lower depth in the tank. The source-to-surface distance (SSD) is 100 cm for
both measurements and 100 MU are delivered. A bias voltage of –300V is set on the
electrometer. The correction factor is obtained by dividing the measurement with the acrylic
by the measurement without the acrylic and is expected to be close to unity as the effective
density of acrylic relative to water is 1.15 (Khan 1994).
The TG-51 calibration protocol is followed to obtain dose values at the CAX. The ion
chamber is placed at a depth of 10 cm below the surface of the water and an SSD of 100 cm is
again used. Three readings each are taken with at electrometer bias voltages of + 300 V, -300
V and - 150 V with 100 monitor units (MU) delivered. For each bias voltage, the three
measurements are averaged together. The final measurements are designated as M A , M B
and M C for the bias voltages of + 300 V, -300 V and –150 V, respectively. A fourth
measurement, M D , is determined by taking a cumulative reading from the electrometer at a
bias voltage of -300 V from four exposures of 25 MU each. Units for measurement is
Coulombs (C) or readings (rdg).
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The dose at 10 cm is determined by the following equation, equation 3.1:
D10 cm = M B • PTPC • Pion • Ppol • ECF • N

correction factor, where PTPC is

Co − 60
w

tissue

µ
is the temperature/pressure
• KQ •
. P
ρ water TPC

273.15 + T ( °C )
760.0
•
; this corrects the charge or
P( mmHg )
295.15

measured current to the standard environmental conditions at which the equipment was
calibrated. Pion , the recombination correction factor, takes into account the incomplete
collection of charge from an ion chamber and is determined by dividing M B by M C . Ppol is
the polarity correction factor, which accounts for any polarity effect on the response of the ion
chamber and is computed as

MA + MB
. ECF , or Pelec , is the electrometer correction factor.
2• MB

This factor is 1.00 if the electrometer and ion chamber are calibrated together; however, for a
separate calibration of these two instruments, the calibration factor corrects the electrometer
reading to true Coulombs (Almond 1999). These correction factors, along with M B ,
correspond to the fully corrected charge reading from an ion chamber (Almond 1999).
N wCo − 60 is the absorbed dose to water calibration factor for the ionization chamber used
60

in this study, for a Co beam under reference conditions. The quality conversion factor, K Q ,
accounts for changes in the absorbed-dose to water calibration factor between the beam
quality of interest and the beam quality for which the absorbed-dose calibration factor applies
tissue

µ
is the ratio of the
(commonly Co ) and is chamber dependent (Almond 1999).  
 ρ  water
60

photon mass attenuation coefficients of tissue to water. The final dose at 10 cm ( DF10cm ) is
computed by multiplying D10cm by the acrylic correction factor. Verification of the dose rate

34

at d max ( DRd max ) is computed from the dose at 10 cm as DRd max = DF10 cm / DDF10 /( MU + ee) ,
where DDF10 is the depth dose fraction at 10 cm determined from machine data book, and

MU + ee is the addition of the monitor units delivered plus the end effect. This equation will
be referred to as equation 3.2. The end effect is calculated as

100 • ( M D − M B )
.
4•MB − MD

DRd max should be 1.0 cGy/MU as calibrated by MBPCC. By multiplying DRd max by the
monitor units delivered (MU) to the vial, the dose (cGy) at d max is determined.
3.2.3 CGEL-S Polymer Gel Vessel
Presently, the Pinnacle3 treatment plan and the actual dose distribution delivered by
the treatment are being compared by a quality assurance (QA) procedure using XV film and
the RIT system. Approximately 8-13 films per patient are taken on the treatment couch with
the films sandwiched between two 5-cm slabs of solid water. One film each is taken for a
parallel calibration, a perpendicular calibration, a composite, and for each gantry angle at
which the treatment is administered. The films are processed and then analyzed by the RIT
system whereby beam profiles and isodose curves are obtained. This process is used to verify
that the calculated dose from Pinnacle3 agree with the dose delivered by the beams.
The film is positioned between the two 5-cm solid water slabs for the perpendicular
calibration film. An SSD of 95 cm is set to the top of the slab (film at 100 SAD), with a
gantry and collimator angle of 180º and a field size of 5 x 5 cm2. Four exposures to monitor
units of 20, 40, 60 and 80 MU are made at different positions on the film. An H &D curve is
obtained for this calibration film using the RIT system. This curve shows the relationship of
the optical density on the film to the applied dose.

35

Seven perpendicular films are then exposed with a similar setup to that of the
perpendicular calibration film. The field size (9 cm x 6 cm), energy (10 MV), SSD (95 cm),
gantry angle (180º), collimator (180º) and couch (180º) are the same for each film exposed.
For these films, the number of monitor units delivered is determined by an in-house
spreadsheet. The input to the spreadsheet is calculated dose rate (cGy/MU) for each field, as
determined by the Pinnacle3 planar dose computation and monitor units are the output. The
“MU delivered” is the number of MU required to achieve 30 cGy on the film at the point of
calculation, an arbitrary point chosen by the experimenter. To determine this point in the RIT
system, the jaw setting in the x and y direction is added to the position determined from the
Pinnacle3 system. The actual monitor units delivered are rounded from the calculated monitor
units (Table 3.3).
XV film is positioned between two slabs of 5-cm solid water to obtain a parallel
calibration film. This time, however, the solid water is placed on its side with its largest
surface area facing the gantry and the end of the couch. An SSD of 100 cm is set to the top of
the phantom with the gantry and collimator angles and the field size remaining the same for
the perpendicular calibration film. The correct position of the setup is determined by aligning
the lateral lasers along the crevices between the slabs and the sagittal laser 15 cm from each
side of the phantom laterally. The dose at d max should be about the maximum dose expected.
in the axial film; in this case, 80 monitor units are delivered to the film. An H&D curve is
obtained for the parallel calibration film as in the case for the perpendicular calibration film.
A parallel composite film is obtained with the solid water in the same position as that
during the parallel calibration film; however, unlike the parallel calibration film, an SSD of 85
cm is set to the top of the phantom. This SSD places the isocenter in the middle of the

36

Table 3.3 Monitor Units for perpendicular films. Monitor units delivered are calculated from a
spreadsheet with the input for the calculated dose rate (cGy/MU) from ADAC. The output is
monitor units (MU). Actual monitor units delivered is rounded from the calculated monitor
units.
Field Name
Calculated dose rate
Monitor units
Monitor units
delivered
calculated from
cGy
(
) from ADAC
spreadsheet
MU
RPO 295
0.884065
33.9
34
Rt Lat 265
0.463454
64.7
65
RAO 225
0.924311
32.5
33
AP 180
0.511203
58.7
59
LAO 135
0.802424
37.4
37
Lt Lat 90
0.404187
74.2
74
LPO 65
0.905329
33.1
33
phantom. Laser alignment is used for correct positioning as in the case of the parallel
calibration film. The field size (9 cm x 6 cm) and energy (10 MV) is the same for each beam;
however, the gantry, collimator, and couch were rotated as indicated by IMPAC, a treatment
verification software system. The monitor units are calculated by the Pinnacle3 system with a
prescription dose of 40 cGy at the isocenter (Table 3.4).
For all films, a pin prick is made in the upper left corner (facing the gantry) on the
film’s envelope. The number of holes pricked is different for each film, allowing the films to
be identified (Table 3.5). Planar doses for the seven fields and the composite are obtained
from ADAC. This information is transferred to the RIT scanning system. All ten films (7
planar dose, one composite and two calibration films) are digitized with the pin pricks
positioned at the bottom left of the film. The isodose curves and absolute dose profiles for
each beam and composite are obtained from the RIT software system, along with the absolute
dose at the point of interest. A scaling factor (MU delivered) is multiplied by the relative
dose rate at the point of interest (

cGy
) from the Pinnacle3 system (Table 3.3) to obtain an
MU

absolute dose measurement. This factor is the actual number of monitor units to be delivered
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Table 3.4 Parallel Composite film. The table summarizes gantry angle, collimator angle,
couch angle and monitor units delivered for each field. Monitor units delivered is computed
from ADAC with a prescription of 40 cGy at the isocenter.
Field Name
Gantry Angle
Collimator
Couch angle
Monitor units,
(degrees)
angle (degrees)
(degrees)
computed from
ADAC
RPO 295
295
180
180
7
Rt. Lat. 265
265
180
180
12
RAO 225
225
180
180
9
AP 180
180
180
180
20
LAO 135
135
180
180
11
Lt. Lat. 90
90
180
180
13
LPO 65
65
180
180
7
Table 3.5 Film Identification. Holes are pricked into each film to distinguish each film after
processing.
Film
Number of Holes
Perpendicular Calibration
1
RPO 295
2
Rt. Lat. 265
3
RAO 225
4
AP 180
5
LAO 135
6
Lt. Lat. 90
7
LPO 65
8
Parallel calibration
9
Composite
10
to each film to achieve a dose of 30 cGy on the film at the calculation point. Both a
horizontal and vertical line are chosen for the dose profiles.
The measured absolute dose at the point of interest is compared to the calculated dose
for the seven perpendicular films. These values are expected to be approximately 30 cGy for
each field. The measured dose on the composite film also is compared to the dose calculated
for the composite field by the Pinnacle3 system; both should be approximately 40 cGy.
A parallel-plate ionization chamber (N23342-868) is used to confirm the absolute dose
at the isocenter for each individual field. Electrometer B is used to measure the current within
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the ionization chamber. The setup for electrometer is as follows: Display: 10 V, Thimble: 300 V, Scale: 10-8 C. This measurement provides another method of measuring the dose. For
the isocentric measurement, the setup is as follows: SSD = 85 cm, chamber parallel to beam
and a 5-cm piece solid water surrounding the center on each side. The setup for the individual
fields include: SSD = 95 cm, chamber perpendicular to the beam and a 5-cm piece of solid
water above the chamber. The setup for the ionization chamber measurement is the same as
that of the composite field setup.
3.2.4 Conclusion
The output of the beam with and without the acrylic is expected to be similar since the
mass density of acrylic is similar to that of water, 1.18

g
g
and 1.00
, respectively
3
cm
cm3

(Khan 1994). The dose rate at d max is expected to be 1.0

cGy
, which is the calibrated dose
MU

rate for the 21EX machine; therefore, the doses delivered to the vials are expected to agree
with the doses obtained with the ionization chamber. The RIT system and films are expected
to confirm that the calculated dose from the Pinnacle3 agrees with the measured dose
produced by the beams. The ion chamber and film measurements provide assurance that the
planned dose is accurately delivered to the CGEL-S vessel.
3.3

Energy Calibration of Polymer-Gel Dosimeter
3.3.1 Introduction
A calibration curve is required to relate the measured R2 to the absorbed dose.

Novotny, et al., reported a linearity with total dose in the range of 0-9 Gy. These calibration
measurements check the linearity of the R2 response to dose. Gels used for calibration must
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be stored, irradiated, and MR-imaged under identical temperature conditions as the
experimental gels.
3.3.2 Procedure
Nine borosilicate glass vials (VIAL in Table 3.1) are purchased from MGS Research,
Inc. to obtain calibration curves. Vial 1 is designated as the unirradiated vial. Vials 2-4 are
irradiated with 4 MV photons to total doses of 1, 4 and 7 Gy, respectively, at a dose rate of
250 MU/min. Vials 5-9 are irradiated with 10 MV photons. Vials 5 and 6 are irradiated to a
total dose of 1 Gy with a dose rate of 400 and 500 MU/min, respectively; Vials 7-9 receive
total doses of 4, 7 and 9 Gy, respectively (Table 3.6) at a dose rate of 400

MU
. The
min

cylindrical vials are placed in a cubic water-filled phantom (35 cm x 35 cm x 38 cm) where a
photon beam from the Varian Clinac 21EX is administered parallel to the cylindrical axis.
The vials are positioned vertically at the bottom of the water tank with approximately 10 cm
of water above the vials (Figure 3.1). A gantry angle of 0° and a field size of 10 x 10 cm2 is
used to irradiate the tank.
The Varian Clinac 21EX is calibrated at MBPCC to give a dose of 1

cGy
at d max
MU

(SSD=100 cm, FS = 10 x 10 cm2), where d max is at a depth of 1.2 cm for 4 MV and 2.5 cm for
10 MV. The radiation beam passes through 1 cm acrylic and 1mm glass at the bottom of the
tube. Because the MRI slices are 2mm thick, it is expected that the slice containing the
maximum dose is slice 1 for the 4 MV photons and slice7 or 8 for the 10 MV photons.
Because of the potential for vial misalignment, the slice at which dmax occurs is not certain.
For the background vial, transverse relaxation rates ( R2 ) are computed for slices 6,7 and 8 for
the 10 MV photons and slices 1,2 and 3 for the 4MV photons. R2 numbers are adjusted
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MU
)
min
and energy (MV) given to each vial. The vials will be imaged via MRI whereby a calibration
curve can be obtained ( R2 vs. dose). Vial 1 is left unirradiated to determine the R2 value
when no dose is given to the gel within the vials (background reading). Due to experimental
error, vial 6 was irradiated to a different dose rate than vials 5 and 7-9.
Energy (MV)
Vial
Total Dose (Gy) MU delivered
Dose rate
MU
(
)
min
1
Unirradiated
0
0
0
2
1
100
250
4
3
4
400
250
4
4
7
700
250
4
5
1
100
400
10
6
1
100
500
10
7
4
400
400
10
8
7
700
400
10
9
9
900
400
10

Table 3.6 Vial Irradiation. The table gives total dose (Gy), monitor units, dose rate (

according to the ratio discussed in Chapter 3.4.2. The smallest R2 value observed in these
slices is designated as the R2 value for vial 1. For the irradiated vials, one axial slice in each
vial receives the desired dose at d max . Within these vials, R2 is computed for the first axial
slices 6,7 and 8 for the 10 MV beam and slices 1,2 and 3 for the 4 MV beam. The largest
value is used as the R2 at d max (Chapter 3.6.6). A graph of R2 vs. absorbed dose is produced
(Chapter 4.5), which is the calibration curve. Two calibration curves are computed, one that
includes background subtraction (y-intercept=0) and one that does not include background
subtraction (non-zero intercept). The slope of the linear portion of the calibration curve gives
the gel sensitivity. The storage, irradiation and temperature during MR imaging of the gel
vials used for dose calibration and the large experimental gel were kept under identical
conditions. All MRI scanning is performed at the same time post-irradiation.
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3.4

Application of BANG-3TM Gel Dosimetry for the Verification of an IMRT
Treatment Plan
3.4.1 Introduction
Verifying a plan with the BANG-3TM polymer gel would be a tremendous boost to

MBPCC in terms of having a modality to image 3D dose distributions of an IMRT plan.
Equipment utilized in this study includes one BAREX CGEL-S vessel, one fiducial marker
set, the Pinnacle3 treatment planning system, the Varian Clinac 21EX and the MRI scanner.
The role of each piece of equipment is briefly discussed.
3.4.2 Procedure
The CGEL-S vessel is filled with BANG-3TM polymer and is used to verify the IMRT
plan in three dimensions (Figure 3.2). A BAREX plastic cylinder contains the BANG-3TM
polymer gel. A set of fiducial markers (SCM set) is used for alignment purposes. The SCM
set contains 4 vinyl suction cups and 5 CT/MRI fiducial marker cups; the vinyl suction cups,
intended for stereotactic radiosurgery, are not used. The fiducial markers are placed on the
outside of the gel. A central cavity within the fiducial marker cup remains empty during CT
scanning but is filled with water for MRI scanning. A syringe is used to fill the cavity with
water; care is taken to prevent air bubbles in the cavity.
The CGEL-S phantom is positioned on the CT scanner table. The crosshairs from the
alignment lasers are marked on tape placed on the outer surface of the phantom. The marks
facilitate repositioning of the phantom for irradiation and imaging. Five fiducial markers are
placed at various positions on the phantom’s surface. An outline of the fiducial markers is
traced on the phantom just in case the marker falls off of the phantom. A CT scan of the
CGEL-S phantom is acquired and sent to the Pinnacle3 treatment planning computer. A
simulated IMRT treatment is planned; the plan is a prostate treatment with seven fields
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Figure 3.2 Photograph of the irradiation set-up of the BAREX CGEL-S vessel used in this
study. The irradiation consisted of a seven-field prostate technique (see Appendix A). The
photo shows the gantry angle of 270°. One sees on the phantom the repositioning mark and
fiducial markers.
(Appendix A). Contours of the right and left femoral heads, prostate, bladder and rectum are
drawn and an optimal isodose distribution around these structures is computed. With this
prostate plan, dose prescribed to the center of the prostate (isocenter) is 2 Gy, while the dose
to the organs-at-risk is kept under 1 Gy.
To irradiate the gel, the treatment plan is first transferred to the IMPAC record and
verify system used at MBPCC. This system allows the physicist/dosimetrist a means to
monitor the radiation delivered to a particular patient and also provides a mechanism to view
the important parameters used during treatment (e.g., couch, gantry and collimator positions).
Two days prior to irradiation, the gels are placed in the 21EX treatment room and
stored in a cardboard box. This step allows for thermal equilibrium within the gel but was
later determined to be very costly as the gel received excess scattered radiation from patient
treatments and leakage radiation from the machine head. These excess doses are measured to
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attempt to determine the amount of excess radiation. The scattered radiation measurement
will be an approximate value due to the inability to recreate the patient treatments, while the
leakage radiation will be somewhat of an absolute value as it will be calculated from the
monitor units delivered in those two days. Within the CGEL-S phantom, unirradiated regions
are analyzed for scanning sessions 1-4. As the dose is expected to be zero, the R2 values
should be approximately the same for all sets of images. In an attempt to correct for any
excess radiation, a dose correction factor is applied. The R2 value for the vials for scanning
session 1 (unirradiated vials) are compared to vial 1 (unirradiated vial) from scanning session
3. If no contamination is present, these values should also agree. If some contamination is
present (i.e., unirradiated vials do not agree) then the R2 values will be adjusted according to
the ratio of the R2 values of the two scanning sessions. This ratio is known as the dose
correction factor.
For irradiation, the gel is mounted on the treatment couch of the Varian Clinac 21EX
with the lasers aligned to the crosshairs traced from the CT scanner lasers. An SSD of 91.3
cm places the prescription point at the center of the gel. However, the lasers alignment
indicated an SSD of 92.8 cm. In turn, the couch was lowered by 1.5 cm to give the
appropriate SSD whereby the coronal lasers were no longer aligned with the crosshair mark
on the tape. An irradiation with 10 MV photon beams is then administered to the phantom.
The 21 EX contains MLCs and uses a “step and shoot” approach to perform the IMRT
treatment. An MRI scanner located at OLOLRMC is used to image the dose distributions
within the BANG-3 TM gel.
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3.4.3 Conclusion
This part of the experiment focuses on the use of the BANG-3TM polymer gel
dosimeter to obtain quantitative dose distributions from an IMRT treatment. Comparison of
the dose map obtained from the MRI scanner to that of the IMRT treatment plan of the
Pinnacle3 system is described in Chapter 3.6 and Chapter 4.6. Dose distributions are
contained within the polymer gel. Dose maps from the MRI scanner are expected to agree
with a slight deviation due to the exposure of the gel to scattered radiation in the treatment
room.
3.5

Imaging of the Calibration Vials and the CGEL-S Vessel
3.5.1 Introduction
Imaging of the polymer gel provides useful information regarding the amount of

polymerization within the gel. Imaging of the BANG-3TM polymer gel is done by either MRI
or optical-CT. Though optical-CT may have advantages over MRI, the scans in this study is
done with the latter due to availability. Two types of pulse sequences are used for the MRI
imaging of a polymer gel: multiple spin-echo sequence and the single echo (Hahn spin-echo
sequence); the user is free to decide which sequence to use.
Four separate imaging sessions are conducted in order to monitor the gel at separate
times in the study. The first session images the CGEL-S phantom and the nine borosilicate
vials (session 1). This information is useful in determining optimal parameters for viewing
the gel and can be used for background subtraction of the vials. Upon completion of the CT
scan, a second image of the CGEL-S phantom is taken (session 2) in order to perform
background subtraction on the gel within the phantom. An image is useful at this time due to
the possibility of contamination of the gel due to light, temperature variation and the CT
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scanning. Minimal contamination is expected as the gel is stored at room temperature away
from light and CT scanning delivers less than 5 cGy dose to the gel. Images of the preirradiated gels are later used to compare the R2 values of the unirradiated gel (scanning
sessions 1 and 2) to the R2 values in the unirradiated vial (scanning session 3). During session
2, marks are placed on the coils to allow a repositioning of the phantom during the next
imaging session.
After irradiation, imaging of the polymerization is necessary to obtain maps of the
dose distribution. Both the CGEL-S phantom and borosilicate vials are imaged in session 3.
A fourth imaging session of the CGEL-S phantom is done approximately two months postirradiation (session 4) to determine the stability of the gel and its usefulness at later times.
Certain precautions must be taken during imaging to obtain optimal results from the
MRI scanner. These precautions include the temperature dependency of the gel, proper
calibration of the scanner and laser misalignment. BANG-3TM gels are temperature dependent
and because of this dependence the gels must be equilibrated to room temperature before
imaging. MGS Research, Inc. recommends that the gel be allowed to equilibrate to room
temperature for two days prior to imaging. Also, it is suggested that both the calibration vials
and the gel phantom be kept at similar temperature conditions to provide consistency between
the measurements. Information on the scanner calibration and coil calibration were obtained
from the MR technician (Guy MRI). From this conversation, it was determined that the
scanner was calibrated but the coils were not calibrated. Finally, through discussions with the
MR technician, it was determined that preventative maintenance is performed on the
alignment laser once per month, assuring us that the laser position has not changed between
scanning sessions.
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3.5.2 Procedure
Imaging is done using the MRI scanner at OLOLRMC. All gel samples are left in the MRI
room two days prior to imaging to allow them to become thermally equilibrated to the room
temperature. Recommendations for the parameters of the scan have been given by the MGS
Research, Inc. website and are closely followed for MRI scanning (Table 3.7). The actual
parameters utilized in this study are shown in Table 3.8. The MRI should not be delayed by
more than one week after irradiation. For all sessions, the Hahn spin-echo sequence is used
for localization, proton density maps and T2 maps. Vials 1, 2 and 3 are placed on the bottom
row, 4, 5 and 6 on the middle row and 7, 8 and 9 on the top row. Localization scans are done
to determine the position of the gel within the head coil. Repetition times (TR), slice
thickness, pixel size, field of view, and acquisition matrix size are the same for all sessions.
Also, all scans took place in the head coil. Within each session, the echo time (TE) is
changed from 21.8 ms (TE1 ) for proton density images, carrying information on coil
sensitivity and spatial non-uniformities of the flip angle, to 116 ms (TE2 ) for a heavily
T2 -weighted image, carrying information on the dose distribution. Thirty-seven slices are
used to image the vials, while seventy slices are used for the imaging of the CGEL-S
phantom. An interleaved acquisition is used to eliminate magnetization cross-talk between
neighboring slices. Acquisition times for the vials (10 min) are shorter than times for the
CGEL-S phantom (17 min) because of the fewer slices. The field of view (FOV) is 22 x 22
cm2 for an acquisition matrix of 192 x 192 pixels. Data is reconstructed into a 256 x
256matrix upon imaging. Eight acquistions are averaged for each slice (NEX=8). All image
data are transferred to an in-house computer at Louisiana State University and analyzed with
IDL software (Research Systems, Inc.). Data is also transferred to a DAT tape for backup.
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Table 3.7 MRI parameter recommendation. Parameters recommended by MGS Research,
Inc. to obtain optimal results when imaging (MGS website).
Parameter
Instructions
Pulse sequence
Hahn spin-echo (single echo); TR at least
1000 ms; First acquisition: TE=20 ms,
Second acquisition: TE=100 ms
Transmitter and receiver gains
Keep constant for both TE acquisitions.
Multiple slices
Use Interleave mode (i.e. acquire slices #1, 3,
5, 7, etc., then #2, 4, 6, 8, etc.); long TR may
be necessary to accommodate many slices to
cover the required volume of the gel.
SNR
Use smallest coils available: head coils or, for
smaller gels, extremity coils. Use spacers to
position the gel in the center of the coil; use
the largest pixel size (i.e. the smallest image
matrix and/or the largest field of view) that is
acceptable to your specific study; use as
much signal averaging as possible, especially
for longer TE’s, as they produce weaker
signals; consider using longer TR for more
magnetization recovery.
Consistency
use the same parameters for all gels in the
experiment for consistency
Table 3.8 MRI Parameters. Coil type, echo time (TE), repetition time (TR), slice thickness,
pixel size, field of view and number of acquisitions used for each session. Session 1 was
performed 3 days after the gels arrived. Session 2 was performed 3 days after the CT scan.
Session 3 was performed 5 days after irradiation, while session 4 was performed
approximately two months after irradiation.
acquisition FOV(cm2) acquisitions
Image coil TE(ms) TR(ms)
slice
type
thickness(mm)/ matrix size
(averaging)
(pixels)
spacing (mm)
proton
21.8
density head
1300
2/2
192x192
22x22
8
T2
116

To qualitatively examine the location of the treatment volume in the gel phantom, the
T2 images alone are used. Quantitative R2 maps are computed from the T2 and proton
density image data. The transverse NMR relaxation rate ( R2 = 1/ T2 ) of the water protons in
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the BANG-3TM gel is proportional to the dose ( R2 = R0 + kD ). R2 maps are produced by the
following equation: R2 =

1
S (TE1 )
ln(
) . S is the signal strength (i.e., pixel values) for
TE2 − TE1 S (TE2 )

the images. From the R2 maps and the vial calibration, the quantitative dose maps are
obtained.
The use of background subtraction is investigated within the CGEL-S vessel by
subtracting the R2 value obtained from scanning session 2 from the values obtained from
sessions 3 and 4. The zero-intercept calibration curves (Chapter 3.6.6) are used to obtain the
dose maps within the vessel when image subtraction is performed (Chapter 4.5).
3.5.3 Conclusion
An accurate MRI image is important for determining the relation between the
transverse relaxation rate and the distributed dose. With this information, dose maps are
determined, whereby the IMRT plan is verified. Data that account for background subtraction
are expected to be more accurate than the data with no subtraction; subtraction should
minimize the effects of imaging artifacts or photopolymerization of the gel. Proper
precautions for thermal equilibration are followed because the BANG-3TM polymer gel
reportedly is dependent upon temperature during imaging.
3.6

Comparison of Measured to Planned Dose Maps
3.6.1 Introduction
IMRT treatments have recently become common at MBPCC. Through the use of the

BANG-3TM polymer gel dosimeter, the 3D-dose distribution from an IMRT treatment is
obtained by MRI imaging of the irradiated polymer gel. Sub-micron sized polymer particles
are formed within the gel. These polymer particles locally alter the T2 of the gel, producing
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3D images of dose distribution (MGS Research website). Comparison of the Pinnacle3
treatment plan to the dose map obtained from the polymer gel provides a means of verifying
the IMRT plan in three dimensions.
Comparisons are made through the use of the IDL computer program. Dose matrices
are obtained for both the Pinnacle3 planning system as well as the polymer gel, whereby these
individual maps are compared. Dose maps within the polymer gel are determined at two
separate times post-irradiation, 5 days and approximately two months. Image subtraction,
point by point, is done by subtracting the dose matrix of MRI/polymer gel from the dose
matrix of the Pinnacle3 planning system. Finally, dose-volume analysis from Pinnacle3 and
the MRI is compared. The dose within the prostate volume and OAR volumes is computed
with IDL and compared with the data obtained from the Pinnacle3 system. Global dose
volume analysis is also conducted, whereby dose is analyzed plane by plane. Qualitative
comparisons are made by analyzing the shape of the contours and color images for the
Pinnacle3 dose maps and MRI dose maps.
Several data-processing steps are required for generating and comparing the dose
matrices. Such procedures include: the elimination of noise fluctuations and background
(non-gel related) regions, the alignment of the MR images to CT images as well as alignment
of the pre-irradiated MRI images to the images obtained post-irradiation, image rotation and
image subtraction. From this point, the R2 -dose calibration curve and the dose matrix are
obtained along with the comparison of the dose maps from the treatment plan and the polymer
gel.
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3.6.2 Procedure
Once the gel has been irradiated and scanned, the polymerized region within the gel is
ready to be analyzed. When compared to the treatment plan, images of the polymer gel will
demonstrate the effectiveness of BANG-3™ polymer gel as a 3-D dosimeter. Expected dose
distributions are computed by the Pinnacle3 planning system software. IDL, a commercial
data processing and analysis software package, is used to determine the measured dose
distribution from the polymer gel images. IDL is also used to compare the two sets of data by
image subtraction, contour comparisons and dose-volume analysis.
Upon completion of the MRI scans, the gel images are saved on both an optical disk
and a DAT tape for later analysis. The images are transferred to the CT scanner from the
optical disk, followed by a network file transfer (ftp) of the data to a computer at Louisiana
State University (LSU). The CT images of the polymer gel are also transferred to LSU. Dose
information from the treatment planning system is transferred manually by a floppy disk to
the same computer as that for the MRI and CT data. From this point, IDL codes are
developed to perform the data processing and comparisons, as described in the following
sections. The IDL code is included in Appendix B.
3.6.3 Noise Fluctuations and Dose Points Outside the CGEL-S
When performing the calculation to determine the R2 values from the echo times and
signal intensities, a problem occurs in pixels where S (TE2 ) = 0 and

S (TE1 )
< 1 . The latter
S (TE2 )

case results in negative R2 values, which is impossible as it implies a negative relaxation time,
while the former situation gives undefined results due to division by zero. To avoid these
problems, pixels exhibiting the above characteristics are excluded from the R2 calculation and
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assigned values of zero. Because the FOV (22 cm x 22 cm) is larger than the CGEL-S
phantom (17 cm diameter), the problem points correspond to background noise fluctuations in
the regions outside the phantom and are ignored with no major consequences.
Also, to remove noise fluctuations, a circular mask (Appendix B) is set around the
CGEL-S vessel, whereby any points outside of the mask are set to zero and all points inside
are set equal to one then analyzed. These masks are developed for the two post-irradiation
image sets (scanning sessions 3 and 4) and the pre-irradiation image (scanning session2). The
diameter ( d ) of the region to mask is determined by first viewing the profiles of the gel and
its components (profile function) then analyzing which points corresponded to outer surface
of the gel. From here, the radius ( r ) of the masked region can be determined ( r =

d
). These
2

surface points are computed in the x and y coordinates. The central point of the circular
region is computed by taking the average of the surface points determined from above.
3.6.4 Alignment of CT and MRI Images
With data information being obtained at different time intervals, reproducible gel
positioning is a matter that must be addressed. A single CT scan is taken of the gel for
planning purposes and four MRI images of the gel are taken over a two-month span. Ideally,
the gel will be lined up in the same position for the CT scan and the four MRI scans; however,
this perfect alignment is hard to obtain and is not expected. Therefore, steps are taken to
allow for correction of small misalignments of the CGEL-S phantom. Alignment corrections
of the vial images are not attempted due to the fact that reproducible positioning from scan to
scan of all nine vials was unfortunately neglected, thus it would be impossible to accurately
align the vials. However, the method used to compute the R2 -dose calibration data from the
vials does not depend on accurate vial alignment as described in Chapter 3.3.2.
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The first step taken to properly align these images is the placement of fiducial markers
and crosshair marks on the gel prior to the CT scan. The laser crosshairs are used as reference
points for subsequent irradiation and MRI scans. The fiducial markers were previously
described in Chapter 3.4.2. During analysis, the location of the fiducial marks between the
MRI scans and CT scan are compared to determine the proper rotations, shifts and scaling to
align the various image data. Shifts and rotations of the gel images from MRI sessions 3 and
4 are needed for alignment with the CT scans (the MRI scans are shifted and rotated relative
to the CT scans). The gel images from MRI scanning session 2 are shifted to align with the
data from MRI scanning sessions 3 and 4 (i.e., pre-irradiation scans are shifted to align with
the post-irradiation scans).
To determine rotation angles, the location of the central cavities of the fiducial
markers and the center of the gel cylinder are calculated for the CT scan and MR images.
Three markers are analyzed; two marks appear in slices 23 and 19 in the CT scans
(corresponding MRI slices at slice 40 and 47, respectively). The CT scans are cropped in
matrix size from 512 pixels x 512 pixels to 409 pixels x 408 pixels then rebinned to 256
pixels x 256 pixels to convert the CT and MRI images to identical image sizes. From here,
the deviation of the fiducial marker position is computed by determining the angle between
the marker and the adjacent axis. The horizontal axis was the reference axis for marker in
MRI slice 40 (CT slice 23) while the vertical axis was the reference axis in MRI slice 47 (CT
slice 19). A third slice with the third fiducial marker (MRI slice 13, CT slice 40) is examined
for the MRI data from session 3 to check the computed rotation angle. Built-in IDL
functions are used to do the actual matrix rotation. Due to an observed slanting of the vials
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and gel vessel in the x and y directions, rotations are also considered for out-of-plane
situations, whereby a rotation function “rot function” is developed and used (Appendix B).
3.6.5 Image Subtraction
Image subtraction is important for data analysis because it allows for exclusion of
polymerization reactions that occurred prior to irradiation. These unwanted reactions occur
because of contamination from oxygen, light or dose from the CT scanner. With image
subtraction, the measured change in R2 values is the result of irradiation only. Before
subtraction of the images can occur, the gel image data must be correctly aligned. In this
study, the MRI image sets are rebinned from 256 pixels x 256 pixels to 512 pixels X 512
pixels in order to provide more precision in the shift. The shift magnitude is selected visually
from overlays of the shifted images. The shifted pre-irradiation values from session 2 are
subtracted from the post-irradiation R2 data (session 3 and 4). The zero-intercept calibration
curve (Chapter 3.6.6) is used to determine the dose distribution within the images.
3.6.6 R2-Dose Calibration Curve
For the R2 -dose calibration, values are obtained for 4 and 10 MV photons with and
without image subtraction. Relaxation rates ( R2 ) are determined in a 3 pixel X 3 pixel region
of interest with the center of this region positioned at the centers of the vials. The R2 values
are determined for slices 1, 2 and 3 for the 4 MV beam and 6, 7 and 8 for the 10 MV beam.
The largest average R2 value for the three slices is used in the calibration curve. With this
information, a comparison is made between the calibration curves for the pair of photon
energies. As the depth of maximum dose is at 2.5 cm for the 10 MV photons and 1.2 cm for
the 4 MV photons, one expects to observe this maximum R2 at depths of 1.4 cm and 0.1cm,
respectively (due to 1 cm acrylic for bottom of the tank and 1 mm glass in the vial), from the
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bottom of the gel in the vials. The corresponding slices are slice 7 for 1.4 cm and slice 1 for
0.1 cm. For the unirradiated vial, the R2 values are determined by taking the smaller value in
slices 6-8 for the 10 MV photons and slices 1-3 for the 4 MV photons.
Calibration curves are generated with Microsoft Excel with delivered doses plotted on
the x-axis and R2 values on the y-axis. For both photon energies, a trend line is fit to the
graphs produced and a linear equation is determined. For cases where background subtraction
is analyzed, a zero-intercept calibration curve is generated as the y-intercept being set to zero.
3.6.7 Dose Maps From Pinnacle3 and Polymer Gel
R2 values are determined for each pixel within the cylindrical gel vessel by the same
calculation used to determine the values within the vials. The R2 map within the gel is
determined 5 days post-irradiation and approximately two months post-irradiation. Because of
the increased dose expected in the images obtained 2 months post-irradiation, an age dose
correction factor is used to better depict these images. The correction factor is determined by
dividing the maximum dose obtained from the images in scanning session 3 by the maximum
dose obtained in scanning session 4. This age correction is discussed in Chapter 4.6.3 and is
shown in Figure 4.24.
The MRI scans used a 22 cm X 22 cm FOV and a pixel size of 0.086cm x 0.086 cm.
The Pinnacle3 software has the capabilities of determining the dose values for every pixel in a
specified region of interest. The field of view and pixel sizes are also set to 22 cm x 22 cm
and 0.086 cm x 0.086 cm, respectively. Accordingly, the Pinnacle3 boundary region data is
examined at pixel sizes of 0.086 cm x 0.086 cm. Dose values are obtained for every pixel of
each slice from the inferior edge of the gel vessel to 10 cm superior to this boundary in
increments of 2 mm. Dose information above this boundary is expected to be zero. Data
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from the Pinnacle3 is transferred to the same computer as that used for the dose maps from the
polymer gel.
3.6.8 Dose Error
For a pixel in a gel image with a measured R2 value, the absolute dose error ( σ D ) can
be computed with the following equation:

( R2 • σα ) 2 + (α • σ R2 )2 + (σ R0 )2 (Baldock 1999).

In this equation, R2 is the measured relaxation rate, σα is the slope uncertainty, α is the slope,
σ R2 is the relaxation rate uncertainty and σ R0 is the uncertainty in the y-intercept. Units are in

cGy. R2 , σ R2 and α are values that can be measured, whereas σα and σ R0 are values that are
computed from the least-squares fit of the calibration data. It has been reported that the
smallest percent error occurs at higher doses and the most significant uncertainties are due to
σ R0 for low doses and σα for high doses (Oldham 1998).

3.6.9 Data Comparisons
Once the proper procedures are performed prior to data acquisition and the results
have been acquired, comparisons between the Pinnacle3 and polymer gel dose distributions is
done. Three techniques used for comparisons are image subtraction, contour shapes and dose
volume analysis. All three techniques are performed with an in-house computer program
using IDL (Appendix B).
For image subtraction analysis, the average dose difference and standard deviation is
computed both globally for each plane (94.4 SPD-104.4 SPD) and locally for points within
the regions of interest (e.g. prostate, femoral heads, bladder and rectum). These points are
determined from a Pinnacle3 file, where the boundary regions from the Pinnacle3 file around
the organ volumes is converted from units of cm to pixels. The data points are examined at a
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slice thickness of 2 mm slices; this is the slice thickness used throughout this study.
Programming allows for a determination of which pixels correspond to the organs of interest.
Contour analysis is used for a qualitative comparison between the Pinnacle3 dose and
MRI dose. The planes analyzed are between 98.6 SPD and 101.6 SPD as this region contains
the area of interest (i.e., isocenter, critical structures and tumor volume). Doses contoured are
200 cGy, 190 cGy, 180 cGy, 150 cGy and 100 cGy. In some figures, the organs of interest
are included at 100 SPD along with the contour levels from both the Pinnacle3 plan and MRI
measurements. MRI measurements are shown for 5 days and two months post-irradiation.
For the same pixel regions used in image subtraction analysis, the total volume within
each organ is determined, whereby the total dose within the organ volume is computed
(DVH). The total volume of each organ determined is compared to the volume obtained by
the Pinnacle3 plan. This procedure allows for a verification of the volume used in the dosevolume-histograms. The measured data are shown with and without the dose correction
factor (Chapter 3.4.2). Also, the total dose plane-by-plane for each contour region (100 cGy,
150 cGy, 180 cGy, 190 cGy and 200 cGy) per volume (cm3) from the Pinnacle3 system and
MRI is compared. MRI data is shown both with and without the dose correction factor
(Chapter 3.4.2). Finally, the maximum dose measured with MRI and calculated with the
Pinnacle3 for each plane is compared. Again, MRI data is shown with and without the dose
correction factor.
3.6.10 Conclusion
This section discusses the methods involved with comparing the dose maps obtained
from the polymer gel and the Pinnacle3 planning system. All computer programming is done
with the IDL software. Proper corrections must first be applied to ensure compatibility
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between the image sets. Removal of noise fluctuations and background dose points, as well
as alignment corrections, are key steps. Also, image subtraction is suggested to eliminate data
from polymerization that occurs before irradiation. Methods to obtain dose maps for the
polymer gel from the R2 -dose calibration curve and the maps from planning using the
Pinnacle3 software are explained.
Three procedures are described to compare the data sets, including: image subtraction,
contour analysis and dose-volume analysis. For image subtraction, an ideal result would be
zero, which implies no difference between the Pinnacle3 plan and the polymer gel dose map.
Results chosen to consider the study a success would be a difference in the data sets of 5% of
maximum dose that can be delivered to the gel. Contour shapes are expected to agree
between the MRI data and CT data. The desired difference in dose analysis results is 5% dose
agreement. The Pinnacle3 treatment planning system and the dose map obtained from the
polymer gel are expected to agree if the images are properly aligned. Alignment is very
important as a deviation of even 1 mm can lead to inaccurate results.
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Chapter 4
Results
4.1

Dose Verification
4.1.1 Correction Factor
With the presence of acrylic, the measurements were 1.398, 1.399 and 1.399 with the

average of these three numbers at 1.399. When acrylic was removed from the radiation beam,
the three measurements were 1.406, 1.405 and 1.405 with the average at 1.405. Dividing the
beam average with acrylic by the beam average without the acrylic, a correction of 0.996 was
computed.
4.1.2 Central Axis Dose
The measurements, M1, M2 and M3 and their averages/cumulative measurement for the
four sets of data taken can be found in Table 4.1. Also, the number of monitor units delivered
and the bias voltages set on the electrometers can be found in this table. PTPC was
computed to be 1.003. The ECF, determined by the calibration company, was 1.002 X 10-8
C
. Pion and Ppoly were also calculated and were found to be 1.004 and 1.000, respectively.
Rdg
The water calibration factor ( N wCo −60 ), obtained from the calibration company was 53.62 X 108
cGy
. K Q was found to be 0.979 for the PTW-30006 chamber (Almond 1857). Finally,
C
tissue

µ
, was determined to be 0.99 for 10 MV photons. From equation 1 (see Chapter 3.2.2),
 
 ρ  water
the dose at 10 cm, D10cm was computed to be 75.001cGy. The final dose at 10 cm ( DF10cm )
was computed to be 74.701 cGy.
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Table 4.1 Measurements taken using the TG-51 protocol to determine the dose at d max . MA,
MB and MC are determined by averaging the three reading taken at the respective bias
voltages, whereas MD was determined by taking a cumulative reading of the measurements
Bias Voltage (V)
MU
M1
M2
M3
MAVG/MCVE
+300
100
1.432
1.430
1.434
MA=1.432
-300
100
1.431
1.431
1.432
MB=1.431
-150
100
1.426
1.426
1.427
MC=1.426
-300
4X25
.357
.716
1.074
MD=1.430
The DDF10 was found in a table at MBPCC and was determined to be 0.7326. This
factor is dependent on depth, energy and field size. The number of monitor units delivered
was 100 MU and the end effect was computed to be -0.023. From here, the dose rate at d max
( DRd max ) was computed from equation 2 to be 1.020

cGy
. Vials 2, 5 and 6 were irradiated
MU

with 100 MU, thus the dose at d max was computed to be 102.0 cGy or 1.02 Gy. A similar
multiplication can be done for the 400MU, 700 MU and 900 MU delivered to the remaining
vials yielding doses of 4.08 Gy, 7.14Gy and 9.18 Gy at d max .
4.1.3 Planar Dose
Dose verification methods for the seven irradiated fields can be found in Table 4.2.
Dose data from the Pinnacle3 is compared to the film and ionization chamber dose data. The
jaw setting for each beam is 4.5 cm for x and 3.0 cm for y, while the position determined from
Pinnacle3 for the seven beams, RPO 295, Rt. Lat. 265, RAO 225, AP 180, LAO 135, Lt. Lat
90 and LPO 65 was (0,0), (1.80, 0.10), (0.03, 0.05), (-2.11, 0), (-0.76, 0.42), (-2.06, 0.47) and
(-.039, -0.17). The points of interest (see Chapter 3.2.3) for the seven treatment beams in the
RIT system were calculated to be (4.5, 3.0), (6.3, 3.1), (4.53, 3.05), (2.39, 3.0), (3.74, 3.42),
(2.44, 3.47) and (4.11, 2.83). Leakage from electrometer B was computed to be 0.001 X 10-8
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Table 4.2 Dose verification for the seven irradiated beams using film and an ionization
chamber. Dose values were measured at 100 SAD.
Percent
Difference
Ion chamber
Film dose
Beam
ADAC dose
Film
IC
dose (cGy)
(cGy)
(cGy)
RPO 295
30.06
33.04
30.48
9.914
1.397
Rt. Lat. 265
30.12
29.11
28.27
0.702
6.544
RAO 225
30.50
33.59
30.19
10.130 1.027
AP 180
30.16
32.44
30.39
7.560
0.763
LAO 135
29.69
32.25
28.75
8.622
3.270
Lt. Lat. 90
29.91
31.06
27.21
3.845
9.923
LPO 65
29.88
32.60
30.19
9.103
1.037
Composite
39.01
36.88
no measurement 5.775
N/A
C/600s = 1.67 X 10-14 A. No reading was taken with the ionization chamber for the
composite field. Units for dose are cGy.
Isodose curves at the central axis (100 source-to-axis distance) for the composite film
can be found in Figure 4.1. Absolute dose profiles for horizontal and vertical lines through
the composite field are shown in Figure 4.2 and Figure 4.3, respectively.
4.2

Pinnacle3 Treatment Planning
4.2.1 Dose Distribution
Figure 4.4 shows a transverse, sagittal and coronal slice of the BANG-3TM polymer gel

developed with the Pinnacle3 planning system and imaged with a CT scanner. Within the gel,
the tumor structure (prostate) and normal structures (bladder, rectum and right/left femoral
heads) are shown. These structures are located between 98.5 SPD and 102.5 SPD. Also, the
isodose distributions around these structures can be seen. The dose distributions shown are
the 200 cGy, 190 cGy, 180 cGy, 150 cGy, 105 cGy and 80 cGy isodose lines.
4.2.2

Dose Volume Histogram (DVH)

Figure 4.5 shows a dose-volume histogram for the prostate, bladder, rectum, right
femoral head and left femoral head. The volume of the organ irradiated is depicted on the y-
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Figure 4.1 Isodose curves for the composite field at the central axis. The different colors
correspond to different dose levels: orange = 37cGy, purple = 35 cGy, red = 32 cGy, light
blue = 30 cGy, green = 25 cGy and dark blue = 20 cGy.
axis, while the dose delivered to that particular volume is shown on the x-axis. Dose values
are in cGy. The volume axis is displayed as the normalized volume to the 100% volume
mark and the dose values are displayed to absolute dose. Also, the DVH calculation is
cumulative throughout the entire tissue volume. From this figure, one can see that nearly
100% of the prostate volume (target volume) receives the total prescribed dose (2 Gy). Also,
less than 50% of the femoral heads and rectum receive 50% of the prescribed dose (1 Gy)
along with 50% of the bladder receiving approximately 1.2 Gy.
4.3

Leakage and Scatter Irradiation
For the two days in which the gel vessel and vials were left in the treatment room prior

to irradiation, the total number of monitor units delivered during the treatments was

62

Figure 4.2 Horizontal dose profile comparison between the calculated dose from the Pinnacle3
plan and the measured film dose. The dotted line represents the Pinnacle3 plan and the solid
line refers to the film.

Figure 4.3 Vertical dose profile comparison between the calculated dose from the Pinnacle3
plan and the measured film dose. The dotted line represents the Pinnacle3 plan and the solid
line refers to the film.
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Figure 4.4 This figure shows the tumor structure and critical structures within the BANG-3TM
polymer gel including the isodose distributions surrounding these structures. The structures
are defined as follows: prostate = red, bladder = yellow, rectum = purple, right femoral head =
blue and left femoral head = green. The isodose distributions are defined as follows: 200.0
cGy = yellow, 190.0 cGy = dark purple, 180.0 cGy = blue, 150.0 cGy = orange, 105.0 cGy =
green and 80.0 cGy = light purple.

determined to be 23,029, which corresponds to a dose of 23,029 cGy (1

cGy
at d max ) or
MU

230Gy. The average maximum allowable leakage as reported by the standards organizations
(IEC, NCRP and SSRCR) is 0.1% of the total dose delivered. Multiplying this number by the
maximum dose delivered gives the maximum leakage received by the gel, 0.230 Gy (23.0
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Figure 4.5 Dose-Volume histogram showing the dose delivered to a particular volume of the
irradiated structure. DVH lines are as follows: prostate = red, left femoral head = green, right
femoral head = blue, bladder = yellow and rectum = purple. The volume is normalized to the
100 % volume mark and the dose values are depicted as absolute dose in cGy.
cGy). The scattered radiation received by the gel was assumed to be 2 times the leakage
radiation or 46.0 cGy.
4.4

Shifts and Rotations
The horizontal and vertical shifts to match the pre-irradiation images (scanning

session 2) of the gel vessel to the images 5 days post-irradiation (scanning session 3) were –5
pixels and 2 pixels, respectively. These same shifts were –3 pixels and 2 pixels when aligning
the pre-irradiation images with the images obtained 2 months post-irradiation (scanning
session 4). When analyzing the data between the MRI scanning session and CT scanning
session, the horizontal and vertical shifts necessary for alignment were determined to be 7
pixels and -3 pixels for scanning session 3 and 5 pixels and -3 pixels for scanning session 4.
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Table 4.3 shows the data obtained when determining the proper rotation angle for the
CT data compared with the MRI images taken post-irradiation. Two points, point 1 and point
2 were analyzed initially for the MRI images from scanning session 3 (MRIa) and scanning
session 4 (MRIb) and then compared to the images from the CT scan. These points were
chosen at the fiducial marks. From the table, it is evident that the MRIb images were more
aligned with the CT scan images than the MRIa images. The MRIb images were declared
aligned with the CT images as the deviation in angle corresponded to a deviation of threequarters of a pixel at the periphery of the dose matrix. Due to this fact, no rotation was
performed on MRIb images. Because of the larger deviation in the MRIa images compared to
the CT images in the first two points (deviations of more than 4 pixels at periphery of dose
matrix), a third point was added and analyzed. By investigation, it was determined that the
2.4º rotation was the optimal angle when compared to all three fiducial points.
4.5

Calibration Curves/Dose Maps
In section 4.1.2, the dose rate at d max was computed to be 1.020

2.0% higher than the expected dose rate of 1.0

cGy
, which was
MU

cGy
. This increase in expected dose rate
MU

changes the total absorbed dose delivered to the calibration vials. Remember, a particular
number of monitor units was delivered to each vial to irradiate the vials to 1Gy, 4Gy, 7Gy
and 9Gy. The corresponding increase in dose being delivered to the calibration vials was1.02
Gy, 4.08 Gy, 7.14 Gy and 9.18 Gy. The axial slice in which the maximum R2 value was
observed was as follows: vials 2,3—slice3, vial4—slice2, vials 5,6 and 9—slice 7, vial 7 and
8—slice8.
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Table 4.3 This table shows the angle of rotation determined to align the CT images with the
MRI images taken post-irradiation. MRI data was compared with CT data (DiffCT). MRIa
refers to 5 days post-irradiation and MRIb refers to 2 months post-irradiation. Point 1 refers
to the fiducial mark in MRI slice 40 (CT slice 23), while point 2 refers to the fiducial mark in
MRI slice 47 (CT slice19). Point 3 was only used in image MRIa.
Image
Point1
Point2
Point3
MRIa
6.254º; DiffCT=1.644º 12.897º; DiffCT=2.034º 8.427º; DiffCT=2.453º
MRIb
8.239º; DiffCT=0.341º 14.982º; DiffCT=0.051º
N/A
CT scan
7.898º
14.931º
5.974º
R2 values and their standard deviations for vials 1-9 in scanning session 1 were
4.632 ± 0.357, 4.374 ± 0.214, 4.678 ± 0.322, 4.889 ± 0.273, 4.187 ± 0.225, 4.406 ± 0.317,
4.777 ± 0.360, 4.115 ± 0.257, and 4.893 ± 0.246. The average value for these nine vials were
4.550 ± 0.286. The R2 value and uncertainty obtained from vial 1 (unirradiated vial) in
scanning session 3 was 5.947 ± 0.384. The ratio of these numbers (

4.550
0.286
) and (
) was
5.947
0.384

0.765 and 0.744, respectively. This data shows a considerable contamination occurring within
the gel between scanning session 1 and scanning session 3. In order to account for this
discrepancy, the values determined from IDL in scanning sessions 3 and 4 were multiplied by
these ratios with this corrected data being used in the calibration curve.
The R2 -dose calibration curves for the 4 and 10 MV irradiation beams are shown in
Figures 4.6 and 4.7, respectively. The 10 MV calibration curves were used to obtain dose rate
( R2 ) maps from the polymer gel. The unit for dose is Gy, while the unit for the relaxation is
1
inverse seconds ( ). Shown in the graphs are the slope, y-intercept and chi-squared
s
(R2) values for both beams. The graphs are linear up to at least 7.14 Gy (R2 = 0.989) for the 4
MV photons and 9.18 Gy (R2 = 0.994) for the 10 MV photons. The y-intercept values were
similar in both graphs with an intercept of 4.497 for 4 MV photons and 4.695 for the 10 MV
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4 MV R2-Dose Calibration Curve

R2(1/s)

15
10
5
0
0
2
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Figure 4.6 4 MV-R2 Dose calibration curve obtained from the calibration vials. Units for dose
are in Gy and units for relaxation rate ( R2 ) are inverse seconds (1/s). Three vials were
irradiated to 1.02 Gy, 4.08 Gy and 7.14 Gy, while one vial was left unirradiated for a
background measurement. Also shown is the linear fit to the line and the R2 value.

R2 (1/s)

10 MV R2-Dose Calibration
Curve
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Figure 4.7 10 MV- R2 dose calibration curve obtained from the calibration vials. Units for
dose are in Gy and units for relaxation rate ( R2 ) are inverse seconds (1/s). Four vials were
irradiated to 1.02 Gy, 4.08 Gy, 7.14 Gy and 9.18 Gy, while one vial was left unirradiated for a
background measurement. Also shown is the linear fit to the line and the R2 value.
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photons; however, the slopes were somewhat different (0.737 for 4 MV, 0.648 for 10 MV).
The uncertainties were very small with the largest uncertainty for the 4 MV ( ± 0.335) and 10
MV ( ± 0.502) beam occurring at a dose of 0 Gy. For both beams, the uncertainties decrease
as the dose delivered increases. With image subtraction correction, the values for slope were
changed for both sets of data with an intercept of 1.539 for the 4 MV photon beam and 1.305
for the 10 MV beam. R2 value for 10 MV photon beam at a dose rate of 400
± 0.553, while this same value for a dose rate of 500

MU
was 6.963
min

MU
was 6.738 ± 0.406, which
min

corresponds to a difference of (6.963-6.738) /6.738 = 3.339%. The relaxation rate ( R2 ),
relaxation rate error ( σ R2 ) and fitting parameters ( α , σα , Ro and σ Ro ) for the 10 MV photon
beam can be found in Table 4.4.
Average R2 values for an unirradiated portion of the gel in the CGEL-S vessel
(scanning sessions 1-4, position x =1-256, y=127 and z=65) were determined to be 4.600 s-1
for scanning session 1 and approximately 4.800 s-1 for scanning session 2-4. Upon comparing
the average R2 from the calibration vials from scanning session 1 and the unirradiated vial
from scanning session 3 to CGEL-S vessel values, it was determined that the vessel values
were approximately similar to the vials in scanning session 1 (

4.550
= 0.989 and
4.600

4.550
5.947
= 0.948 ) but considerably different from the vials in scanning session 3 (
= 1.293
4.800
4.600
and

5.947
= 1.239 ). There appeared to be an overall non-uniformity (waviness) in the R2
4.800

values of the gel vessel post-irradiation and an artifact in proton density within the vials
(Figure 4.8).
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Table 4.4 Average relaxation rate ( R2 ) and error ( σ R2 ) and fitting parameters for the 10 MV
photon irradiation. Relaxation rare and error were multiplied to the dose correction factor.
Average R2 and error
Dose
0 Gy
1 Gy
4 Gy
7 Gy
9 Gy
delivered
Relaxation
rate ( R2 ) and
R2
σ R2
R2
σ R2
R2
σ R2
R2
σ R2
R2
σ R2
error ( σ R2 )
Measured
values

4.568 0.502 5.328 0.411

7.524

0.454 9.542 0.470 10.390 0.241

parameter
slope
slope error

symbol
α
σα

Fitting parameters
value
0.648
0.424

intercet

Ro

4.695

s-1

intercept
error

σ Ro

0.061

s-1

units
s-1/Gy
s-1/Gy

Figure 4.8 T2-weighted (left) and proton density (right) images obtained from MRI. Vial 1 is
located on the upper left corner of the image and vial nine is located on the lower right corner.
Note the artifacts inherent within the vials of the proton density images.
4.6

Comparisons—Image Subtraction, Contour Comparisons and
Dose-Volume Analysis
4.6.1 Image Subtraction
Figures 4.9 and 4.10 show the dose deviations between the Pinnacle3 (ADAC) data

and MRI data 5 days post-irradiation and 2 months post-irradiation, respectively, for slices 4
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(ADACMRI)

Deviation between ADAC data
and MRI data: 5 days postirradiation with correction factor
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Figure 4.9 Figure showing the global deviation in dose values between the ADAC dose and
MRI dose (5 days post-irradiation). Data takes into account dose correction factor. Values
are shown for MRI slices 4-50. Differences are computed by subtracting the MRI dose values
from the ADAC dose values. Error bars are present.
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Deviation between ADAC data
and MRI data: 2 months postirradiation with correction
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Figure 4.10 Figure showing the global deviation in dose values between the ADAC dose and
MRI dose (2 months post-irradiation). Data takes into account dose correction factor. Values
are shown for slices 4-50. Differences are computed by subtracting the MRI dose values from
the ADAC dose values. Error bars are present.
through 50 (95.0 SPD to 104.2 SPD). Data take into account the 0.765 dose correction factor
(Chapter 4.5). Negative values correspond to a larger MRI dose when compared to the
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ADAC dose. In Figure 4.9, dose differences range from –57.0389 cGy (slice 40) to 17.102
cGy (slice 19). For slices 15-37, the dose values from ADAC and MRI show little deviation
(0 difference) when the uncertainty was taken into account. Uncertainties range from 20.767
cGy (slice 49) to 35.4813 cGy (slice 18).
In Figure 4.10, larger differences were observed between the ADAC data and MRI
data, ranging from –168.983 cGy (slice 40) to –67.380 cGy (slice 5). Larger uncertainties
were also witnessed for this scanning session, with values ranging from 65.730 cGy (slice 30)
to 83.647 cGy (slice 7). In this figure, MRI images and ADAC images do not agree
(difference not equal to zero) even when the uncertainty was considered.
Figure 4.11 and Figure 4.12 also show deviations between ADAC dose and MRI dose
for slices 4-50 for MRI images taken both 5 days and 2 months post-irradiation; however
these figures do not take into account the dose correction factor. In Figure 4.11, average dose
differences range from –83.111 cGy (slice 40) to 5.460 cGy (slice 5) and their deviations
range from 28.555 cGy (slice 14) to 47.751 cGy (slice 4). In Figure 4.12, average dose
deviations range from –199.434 (slice 8) to –88.803 (slice 5), while average uncertainties
range from 85.167 (slice 29) to 109.363 (slice 7). This set of data show higher MRI readings
and a larger deviation between the ADAC data and CT data than data that take into account
the correction factor. Fewer slices show an agreement (0 difference) between the ADAC and
MRI data even when uncertainty is taken into account. Again, MRI data obtained
5 days post-irradiation was more similar to the CT data than the MRI data obtained 2 months
post-irradiation.
Figures 4.13-4.17 show the dose deviations between ADAC and MRI for each slice
within the 5 organs investigated in this report. Values are shown both with and without the
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Deviation between ADAC data and
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Figure 4.11 Figure showing the global deviation in dose values between the ADAC dose and
MRI dose (5 days post-irradiation). Data does not take into account dose correction factor.
Values are shown for MRI slices 4-50. Differences are computed by subtracting the MRI
dose values from the ADAC dose values. Error bars are present.
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Figure 4.12 Figure showing the global deviation in dose values between the ADAC dose and
MRI dose (2 months post-irradiation). Data does not take into account dose correction factor.
Values are shown for slices 4-50. Differences are computed by subtracting the MRI dose
values from the ADAC dose values. Error bars are present.
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Figure 4.13 Figure shows the deviation between the calculated ADAC dose and measured
MRI/polymer gel dose for the prostate. Plotted on the x-axis is the source-to-plane distance
(SPD) ranging from –1.2 cm (98.8 SPD) to 0.8 cm (100.8 SPD). Lower SPDs correspond to
inferior portions of the gel. Plotted on the y-axis is the dose values obtained from the MRI
data subtracted from dose values obtained from the ADAC data. Units are in cGy. The upper
pink line contains values that take into account the dose correction factor while the lower blue
line does not consider this factor.
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Figure 4.14 Figure shows the deviation between the calculated ADAC dose and measured
MRI/polymer gel dose for the bladder. Plotted on the x-axis is the source-to-plane distance
(SPD) ranging from –1.2 cm (98.8 SPD) to 0.8 cm (100.8 SPD). Lower SPDs correspond to
inferior portions of the gel. Plotted on the y-axis is the dose values obtained from the MRI
data subtracted from dose values obtained from the ADAC data. Units are in cGy. The upper
pink line contains values that take into account the dose correction factor while the lower blue
line does not consider this factor.
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Dose deviation between ADAC and
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Figure 4.15 Figure shows the deviation between the calculated ADAC dose and measured
MRI/polymer gel dose for the lt. femoral head. Plotted on the x-axis is the source-to-plane
distance (SPD) ranging from –0.6 cm (99.4 SPD) to 0.8 cm (100.8 SPD). Lower SPDs
correspond to inferior portions of the gel. Plotted on the y-axis is the dose values obtained
from the MRI data subtracted from dose values obtained from the ADAC data. Units are in
cGy. The upper pink line contains values that take into account the dose correction factor
while the lower blue line does not consider this factor.
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Figure 4.16 Figure shows the deviation between the calculated ADAC dose and measured
MRI/polymer gel dose for the rt.femoral head. Plotted on the x-axis is the source-to-plane
distance (SPD) ranging from –0.6 cm (99.4 SPD) to 0.8 cm (100.8 SPD). Lower SPDs
correspond to inferior portions of the gel. Plotted on the y-axis is the dose values obtained
from the MRI data subtracted from dose values obtained from the ADAC data. Units are in
cGy. The upper pink line contains values that take into account the dose correction factor
while the lower blue line does not consider this factor.
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Figure 4.17 Figure shows the deviation between the calculated ADAC dose and measured
MRI/polymer gel dose for the rectum. Plotted on the x-axis is the source-to-plane distance
(SPD) ranging from –1.6 cm (98.4 SPD) to 1.4 cm (101.4 SPD). Lower SPDs correspond to
inferior portions of the gel. Plotted on the y-axis is the dose values obtained from the MRI
data subtracted from dose values obtained from the ADAC data. Units are in cGy. The upper
pink line contains values that take into account the dose correction factor while the lower blue
line does not consider this factor.
dose correction factor. Units are in cGy. From the figures, it is evident that the measured and
planned dose values were in closer agreement with one another when the correction factor
was taken into account; only data that consider the correction factor is discussed here. Aside
from the prostate, the measured MRI data was higher in value than the planned ADAC data.
Within the prostate (center of the gel), the correction factor was shown to overcompensate for
the excess dose delivered to the gel (ADAC dose was larger than MRI dose). The rectum
shows the greatest agreement in dose values, as the difference in dose was nearly zero
throughout the entire volume. The bladder and rt. femoral head also show good agreement
between the dose values as some regions are within 10 cGy of one another. In the case of the
lt.femoral head, MRI values were approximately 30 cGy higher than the ADAC values.
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Dose within each organ was also analyzed for MRI images taken two months postirradiation then compared to the ADAC planned data. Remember, negative numbers
correspond to higher MRI readings. Dose deviation ranges for each organ were as follows:
prostate— -91.0630 cGy to -73.5357 cGy, bladder— -134.951cGy to -102.470 cGy, lt.
femoral head— -161.475 cGy to –143.759, rt. femoral head— -157.901 cGy to –130.959 cGy
and rectum— -115.766 cGy to –77.5087 cGy. Again, a better agreement was seen between
the measured MRI/polymer gel dose and planned ADAC dose whenever the dose correction
factor was considered.
4.6.2 Contour Analysis
Figure 4.18 shows a color contour depicted for ADAC dose distributions planned for
an IMRT treatment. The colors represent different dose distributions throughout the gel
(white: 210-220 cGy, gray: 200-210 cGy, red: 190-200 cGy, reddish blue: 180-190 cGy, blue:
150-180 cGy, light green: 105-150 cGy, dark green: less than 105 cGy). The anterior portion
of the gel is located on top of the image. Images were taken at the central axis (z=0 plane,
100 SPD).
Figures 4.19-4.21 illustrate color contours obtained from the measured MRI dose
distributions via IDL. Contours are shown for two different times post-irradiation
with/without the 0.765 dose correction factor. No graph was generated for the MRI data 2
months post-irradiation without the correction factor as all MRI dose distributions for this
graph was located on the periphery of the gel. The anterior portion of these images was also
located on top of the image. Images were taken at the central axis (z=0 plane, 100 SPD).
Overall, there was no complete agreement between the ADAC planned dose distributions and
the MRI measured dose distributions. For the data obtained 5 days post-irradiation, dose
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Figure 4.18 Figure shows ADAC dose contours within the BANG-3TM polymer gel for a 7field prostate IMRT treatment. Colors are shown to represent the dose distribution throughout
the gel (white: 210-220 cGy, gray: 200-210 cGy, red: 190-200 cGy, reddish-blue: 180-190
cGy, blue: 150-180 cGy, light green: 105-150 cGy, dark green: less than 105 cGy).

Figure 4.19 Figure shows MRI dose contours 5 days post-irradiation with 0.765 correction
factor within the BANG-3TM polymer gel for a 7-field prostate IMRT treatment. Colors are
shown to represent the dose distribution throughout the gel (white: 210-220 cGy, gray: 200210 cGy, red: 190-200 cGy, reddish-blue: 180-190 cGy, blue: 150-180 cGy, light green: 105150 cGy, dark green: less than 105 cGy).
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Figure 4.20 Figure shows MRI dose contours 5 days post-irradiation without the correction
factor within the BANG-3TM polymer gel for a 7-field prostate IMRT treatment. Colors are
shown to represent the dose distribution throughout the gel (white: 210-220 cGy, gray: 200210 cGy, red: 190-200 cGy, reddish-blue: 180-190 cGy, blue: 150-180 cGy, light green: 105150 cGy, dark green: less than 105 cGy).

Figure 4.21 Figure shows MRI dose contours 2 months post-irradiation with 0.765 correction
factor within the BANG-3TM polymer gel for a 7-field prostate IMRT treatment. Colors are
shown to represent the dose distribution throughout the gel (white: 210-220 cGy, gray: 200210 cGy, red: 190-200 cGy, reddish-blue: 180-190 cGy, blue: 150-180 cGy, light green: 105150 cGy, dark green: less than 105 cGy).
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distributions at the periphery of the gel appear to agree with the ADAC data when the dose
correction factor was used. Without this factor, dose distributions near the
center of the gel appear to be more identical. Also, dose distributions obtained 5 days postirradiation were more analogous to the ADAC distributions than were the images obtained 2
months post-irradiation.
Figures 4.22-4.24 show isodose distributions for MRI data and CT data along with the
organs analyzed in the study. MRI data is shown for images 5 days and 2 months postirradiation, along with correction factors. The age correction factor estimates additional
polymerization between imaging sessions and was (Chapter 3) determined for scanning
session 4 to be 1.735; the effects of this factor can be seen in figure 4.24. These images show
that highest dose delivered was to the prostate region. Without the correction factor, for both
the planned ADAC data and measured MRI data, the 180, 190 and 200 cGy contour lines
closely follow the contour of the prostate. Also, the measured and planned data show that
parts of the bladder and rectum receive as much dose as 200 cGy. Lower dose distributions
extend out to the femoral heads (150 cGy) and as far as the periphery of the gel phantom (100
cGy). Data show that the MRI dose contours extend more towards the periphery of the gel
than the ADAC dose contours. High measured dose regions (200 cGy) can be seen in the gel
images obtained 5 days post-irradiation. Finally, when the dose correction factor was used,
lower measured doses can be seen at the center of the gel (larger deviation with planned data)
while measured and planned data towards the edge of the gel appear to be more similar.
4.6.3 Dose-Volume Analysis
The volume for the tumor volume (prostate) and critical structures (lt. femoral, rt.
femoral, bladder and rectum) computed from IDL are 46.266, 15.396, 11.466, 58.202, and
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4.22 Figure shows contours of the dose distributions along with the organs analyzed in the
study. The contours are of ADAC plan (dashed line) and MRI analysis (solid line) 5 days
post-irradiation. The dose correction factor is used in the MRI contours. Images are taken at
100 SPD (z=0). Organ color distributions are as follows: prostate-maroon, rt. femoral headlight blue, lt. femoral head-green, bladder-brownish orange and rectum-purple. Contour color
distributions for dose are as follows: 200 cGy-red, 190 cGy-light blue, 180 cGy-white, 150
cGy-green and 100 cGy-purple.
36.231, respectively. The corresponding volumes from the ADAC plan were 45.549, 15.401,
11.403, 57.752 and 36.241. Units are in cm3. Percent difference in these values are 1.574%,
0.032 %, 0.552%, 0.779% and 0.028%. Figures 4.25 and 4.26 represent the ratios of the total
volume per plane receiving a particular dose of interest (100 cGy, 150 cGy, 180 cGy, 190 cGy
and 200 cGy) measured by MRI/polymer gel relative to the values obtained by ADAC. Dose
is represented by colors, which are blue, pink, yellow, light blue and purple, respectively, for
the regions mentioned above. The inferior portion of the gel is represented with negative
dose regions) and under compensates for this excess dose near the periphery of the gel (ratio
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4.23 Figure shows contours of the dose distributions along with the organs analyzed in the
study. The contours are of ADAC plan (dashed line) and MRI analysis (solid line) 5 days
post-irradiation. No dose correction factor is used in the MRI contours. Images are taken at
100 SPD (z=0). Organ color distributions are as follows: prostate-maroon, rt. femoral headlight blue, lt. femoral head-green, bladder-brownish orange and rectum-purple. Contour color
distributions for dose are as follows: 200 cGy-red, 190 cGy-light blue, 180 cGy-white, 150
cGy-green and 100 cGy-purple.
was greater than 2 in lower dose regions). ADAC and MRI dose appear to be in agreement
within the 150 cGy contour level as the ratio of MRI to ADAC was approximately one
throughout the gel. In some regions within the 190 cGy contour level, some agreement was
seen between the measured MRI data and calculated ADAC data, but more time than not,
MRI values were smaller than the ADAC values. When the dose correction factor was not
considered, MRI measurements were 1.5-3 times larger than the CT measurements for all
dose regions throughout the gel.
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Figure 4.24 Figure shows contours of the dose distributions along with the organ analyzed in
the study. The contours are of ADAC plan (dashed line) and MRI analysis (solid line) 2
months post-irradiation. An age correction factor is used in the MRI contours to account for
the increased polymerization of the gel with time. Images are taken at 100 SPD (z=0). Organ
color distributions are as follows: prostate-maroon, rt. femoral head- light blue, lt. femoral
head-green, bladder-brownish orange and rectum-purple. Contour color distributions for dose
are as follows: 200 cGy-red, 190 cGy-light blue, 180 cGy-white, 150 cGy-green and 100 cGypurple.
Figure 4.27 shows the maximum dose values measured per plane with the
MRI/polymer gel measurements, along with the maximum dose per plane calculated by
ADAC. Dose values are in cGy. Again, the inferior portion of the gel is represented by
negative numbers (lower SPDs). MRI data is shown with and without the dose correction
factor. When the correction factor was considered, planes near the central slices (-2.0 to 1.2)
tend to be similar for both MRI and ADAC, with the MRI readings marginally larger than the
ADAC readings. At x=0 (100 SPD), the MRI reading was determined to be 238.377, while
the ADAC value was determined to be 219.943. This difference corresponds to a percent
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Figure 4.25 Ratio of total dose per volume (cm3) measured by MRI to total dose per volume
(cm3) calculated by ADAC per slice of data (MRI/CT) with dose correction factor. Data
range from 98.6 SPD (-1.4) to 101.2 SPD (1.2). Colored lines represent contour regions (blue
= 100cGy, pink = 150 cGy, yellow = 180 cGy, light blue = 190 cGy, purple = 200 cGy).
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Figure 4.26 Ratio of MRI total dose per volume (cm3) to ADAC total dose per volume (cm3)
per slice of data (MRI/CT) without dose correction factor. Data range from 98.6 SPD (-1.4)
to 101.2 SPD (1.2). Colored lines represent contour regions (blue = 100cGy, pink = 150 cGy,
yellow = 180 cGy, light blue = 190 cGy, purple = 200 cGy).
difference of 8.381%. Away from these planes, MRI readings were consistently higher than
ADAC readings as ADAC measurements dropped to zero and MRI measurements dropped to
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Figure 4.27 Maximum dose values per plane for ADAC (blue), MRI with dose correction
factor (pink) and MRI without dose correction factor (yellow) per SPD slice. Slices range
from 95.0 SPD (-5.0) to 104.2 SPD (4.2). Dose values are in cGy.
as low as 130.910 cGy. With no dose correction factor, the MRI dose and ADAC dose were
not similar. At x=0, the measured MRI dose was 311.604, which corresponds to a percent
difference of 41.675%.
Figures 4.28-4.30 show dose volume histograms (DVH) from the ADAC data and
MRI data. The MRI results are shown both with and without the dose correction factor. The
normalized volume, normalized to the total volume of each organ is plotted as a function of
the absorbed dose received by the polymer gel. All four organs-at-risk (lt. femoral head, rt.
femoral head, bladder and rectum) were analyzed along with the tumor volume (prostate). The
ADAC data show that less than 50% of the volume of the femoral heads and bladder received
a dose higher than 100 cGy, while 50% of the rectum volume received around 120 cGy. No
portion of the femoral heads and only 20% of the rectum and bladder received a dose greater
than 150 cGy. Also, 100% of the prostate volume received at least 190 cGy with around 75%
receiving at least 200 cGy.
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Figure 4.28 ADAC dose volume histogram analyzed with IDL software. Volume is
normalized to the maximum volume within the organ. The normalized volume is plotted as a
function of the dose delivered to the polymer gel. Colors represent the organs analyzed and
are as follows: dark blue diamond—rectum, pink square—lt. femoral head, yellow triangle—
rt. femoral head, light blue x—prostate and purple *--bladder.
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Figure 4.29 MRI dose volume histogram with dose correction factor analyzed with IDL
software. Volume is normalized to the maximum volume within the organ. The normalized
volume is plotted as a function of the dose delivered to the polymer gel. Colors represent the
organs analyzed and are as follows: dark blue diamond—rectum, pink square—lt. femoral
head, yellow triangle—rt. femoral head, light blue x—prostate and purple *--bladder.
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Figure 4.30 MRI dose volume histogram without dose correction factor analyzed with IDL
software. Volume is normalized to the maximum volume within the organ. The normalized
volume is plotted as a function of the dose delivered to the polymer gel. Colors represent the
organs analyzed and are as follows: dark blue diamond—rectum, pink square—lt. femoral
head, yellow triangle—rt. femoral head, light blue x—prostate and purple *--bladder.
Taking the dose correction factor into consideration, the DVH for the MRI data were
as follows: 100% of the prostate volume received 150 cGy with only 10% receiving 200cGy,
50% of the bladder, rectum and rt. femoral head received a dose of around 125 cGy with the
value slightly higher for the lt. femoral head (135 cGy) and finally, less than 20% of these
organs received a dose higher than 150 cGy. In the absence of the dose correction factor, the
measured reading for every organ was higher than in the case with the correction factor.
Accordingly, 95% of the prostate received at least 190 cGy, over 50% of every OAR received
a dose of greater than 150 cGy and with the exception of the rt. femoral head and 10-20% of
the OAR received a dose of at least 200 cGy.
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Chapter 5
Discussion
5.1

Pinnacle3 Planning System
For any cancer center focused on performing a novel 3D-oriented radiotherapy

modality, such as IMRT, a planning system capable of planning in 3-D with good spatial
accuracy is a necessity. The planning system used at MBPCC is the Pinnacle3 planning
system. Images are transferred to the Pinnacle3 workstation upon receiving the scans from
CT. The Pinnacle3 planning system was very useful in this study as it provided the spatial
location of the OAR and PTV, along with the dose distributions surrounding these regions
and a dose volume histogram used to analyze the dose delivered to a particular organ of
interest. At MBPCC, doctor’s requests are that the PTV receives at least 95% of the
maximum dose and that the volume of the OAR receiving a dose above 50% of the maximum
dose is kept to a minimum for prostate treatment planning. The Pinnacle3 plan (Figure 4.4)
demonstrated the optimized plan for a tumor located within the prostate (200 cGy
encompassing most of the prostate, 190 cGy encompassing the entire prostate (PTV) and 105
cGy encompassing approximately half of the volume of the OAR). Also, the dose volume
histogram (Figure 4.5) reconfirmed this requested dose distribution; close to 100 % of the
prostate volume received the maximum dose (prescription dose) of 2 cGy while the dose to
the OAR were kept to a minimum (approximately 50 % of the volume of the OAR received
nearly half (100 cGy) of the total dose).
5.2

Gel Irradiation
The BANG-3TM polymer gel was used in this study for comparison with the Pinnacle3

treatment planning system. In particular, focus of the study was on the response of the gel to
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an IMRT treatment that was planned by the Pinnacle3system. The gel was purchased from
MGS Research, Inc. within a BAREX CGEL-S vessel and borosilicate glass vials. Nine vials
were used for gel calibration and one vessel was used to obtain the images from irradiation,
administered with the Varian Clinac 21EX.
5.3

Dose Verification
In performing this experiment, it was imperative to obtain an accurate R2 -dose

calibration curve as this curve determined what dose was delivered to the main CGEL-S
vessel. As the R2 value was computed from the MRI /IDL readings, the proper dose delivered
to the calibration vials should be accounted for. In setting up the experiment for the
calibration procedure, it was observed that the bottom of the cubic water tank contained 1 cm
of acrylic. It was concluded that an acrylic correction factor should be determined and
applied to the dose calculation at d max , the depth at which the dose to the calibration gel was
computed. A correction factor of 0.996 was determined and, because the composition of
acrylic and water are very similar, this factor is what was expected, a number near unity. The
dose rate at d max is calibrated to be 1.0

cGy
; however, this number should be tested for
MU

validity. Through calculations, the dose rate was determined to be 1.020

cGy
, giving the
MU

dose at d max readings 2% higher than expected. Without the proper attention to these factors
(i.e., acrylic correction factor and dose rate at d max , the dose delivered to the calibration vials
would have been off by as much as 2.5%, which would affect the calibration curve.
Additional dose measurements were acquired with XV film and an ionization chamber
to verify the results obtained with the BANG-3TM polymer gel. Both measurements were
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compared to the Pinnacle3 planning system to ensure that the radiation delivered agreed with
the IMRT plan. The film-based method is the method currently used at MBPCC for IMRT
QA. As can be seen from Chapter 4.1.3, for the individual fields, for the film-based
measurements, five of the seven beams (RPO 295, RAO 225, AP 180, LAO 135 and LPO 65)
did not meet the standard of 5% as stated by ICRU (ICRU 1976). The composite film also
did not meet this 5 % criteria. However, when film uncertainty (~2-3%) and misalignment
issues (i.e., crooked film) were considered, the discrepancies were close enough to justify an
agreement between the plan and the dose delivered. Upon observing the ionization chamber
measurements (Chapter 4.1.3), smaller discrepancies were observed when compared to the
Pinnacle3 dose. The ionization chamber dose measurements were in close proximity to the
values determined from the Pinnacle3 system. These chamber measurements confirm the film
measurements and it was concluded that the dose distribution delivered was similar to that
planned by the Pinnacle3 system.
In addition to the ionization chamber and film measurements, isodose curves and dose
profiles were used to verify the similarities between the Pinnacle3 plan and the irradiated
region. Isodose curves at the central axis (100 source-to-axis distance) for the composite film
clearly show the dose distributions for doses delivered to this axis (Figure 4.1). Curves show
the expected highest dose region around center of the field (37 cGy) and lower dose regions
toward the edges (20 cGy). The horizontal profile (Figure 4.2) shows a somewhat better
agreement with the Pinnacle3 plan than the vertical profile (Figure 4.3) and both profiles
illustrate a higher Pinnacle3 dose than film dose.

90

5.4

Leakage and Scatter Radiation
An improper step was taken during experimentation that potentially caused an error in

the dose measurements. This step involved the placement of the gel (vials and vessel) in the
treatment room two days prior to irradiation as suggested in the “handling of BANGTM gels”
by MGS Research, Inc. (MGS website). As the temperature throughout MBPCC is
approximately constant throughout the center, there was no need to place the gel within the
treatment room. In the two days prior to irradiation, a dose of 23.0 cGy was measured as the
leakage radiation and 46.0 cGy was approximated as the scatter radiation (Chapter 4.3). As
stated in Table 3.2, the dose response is independent of photon or electron energy, thus any
dose received by the gel, the response will be the same regardless of the photon energy.
Therefore, we believe that the excess radiation did affect the gel. As a matter of fact,
contamination was observed within the gel between scanning session 1 and scanning session
3. Unfortunately, there is no way to examine the impact of this radiation throughout the gel.
One option would be to place the gel in the treatment room on Friday and perform the
treatment on Sunday. As treatments are normally not performed on weekends at MBPCC, no
excess leakage or scatter radiation would be received by the gel in this time.
5.5

Imaging
MRI was used to scan the polymer gel on four separate occasions (Chapter 3.5). The

first scan was performed prior to the CT scan and was used for acquiring background
measurements of the gel and for familiarity with the scanning system (i.e., acquisition set-up,
scanning time and gel positioning). A second scan was performed after CT scanning to test
for any contamination within the gel and was ultimately used for background subtraction
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within the CGEL-S vessel. Two additional scans were taken, five days and two months postirradiation, to observe the radiation and aging effects on the gel.
An artifact was observed in the vial proton density images, along with a ring artifact
(non-uniformity) within gel (Figure 4.8). The vial artifact was considered to be a result of the
MRI scanner because it was in same position for each scan, while the vial positions were not.
It is beyond the scope of this paper to determine what caused the artifact and the possible
effects of the artifact on the MRI data. The ring artifacts within the gel vessel were assumed
to be due to MRI equipment, which can be caused by failure or poor adjustment of equipment.
The linearity of the system and thus the center of reconstructions are defined via gradients
rather than being defined geometrically, therefore misalignment may cause ring artifacts close
to the center. Also, ringing is observed to exist near high contrast interfaces in the image
(Webb 1988).
5.6

Analysis with IDL
A major setback inherent in this study was the problem of transferring the images

from the Pinnacle3 system and MRI to the same computer for analysis as the IDL software
was on an on-campus computer at LSU. No files that were in Pinnacle3 format could be
transferred to the campus computer because this computer had no Pinnacle3 software. For the
MRI files, the campus computer was not able to read optical disks and the readings of the
DAT tapes would take weeks to complete. Eventually, all files were sent to the CT scanner,
whereby they were then sent over to the Pinnacle3 workstation and ftp’d to LSU for analysis.
To provide accurate analysis, shifts and rotations of the images were required to align
the MRI and CT data. Shifts were performed on pre-irradiation MRI images (i.e., scanning
session 2) relative to post-irradiation MRI images (i.e., scanning sessions 3 and 4) and on
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post-irradiation MRI images relative to CT images. Rotations were only performed on the
post-irradiation MRI images relative to the CT images. The gel ring artifact (chapter 5.5)
could cause problems when rotating MRI scans to match one another. The problem would
occur when performing background subtraction, as the artifacts would no longer be aligned.
These rotations were not done and should not be performed in future studies if artifacts are
present. Chapter 4.4 summarizes the shifts and rotations performed to align the images. An
inconsistency in using the “rot function” to rotate the vials (e.g., rotated images were still
misaligned) was observed. Due to this discrepancy and the artifact noted in Chapter 5.5,
rotations of the vials were disregarded. Also, no shifts were performed on the vial images
because of the random positioning of each vial in the MRI scans. In each scanning session,
the vials were only taped together and placed in a curved apparatus therefore similar
positioning of the vials between scans is not guaranteed. For future studies, it is suggested
that the vials be placed in an apparatus that keeps the vial positions constant from scan to
scan.
Ideally, it would be preferred that no shifting or rotations were necessary due to a
possible error in the program or the inability to accurately determine proper rotation angles or
shifts (e.g., used get xy function—uncertainty in correct pixel chosen). One suggestion would
be to build a container to house the phantom and vials for scanning and irradiations. This
device would be manufactured to firmly house the phantom and vials and thereby guarantee
no shifting of the gel. A second suggestion would be to use a gel analysis service (e.g., Stony
Brook), whereby all technical aspects of imaging and alignment would be left up to the
professional analysis company. Price ranges would depend on the accuracy and resolution
desired because longer necessary scanning times are necessary. An accuracy of 1-2% and
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resolution of 1 mm is possible (personal communication). Stony Brook also will soon be
offering their DoseQA3-D software, possibly free of charge that is compatible with DICOMRT (Stony Brook website).
Finally, through analysis, some uncertainty existed as to the orientation of the gel in
the Pinnacle3 system (i.e., superior/inferior end). This presents a problem when comparing
the Pinnacle3 data to the MRI data, as larger deviations would result if the wrong ends are
compared. From this observation, it should be noted that there are optimum locations with
which to place the fiducial markers. For example, at least one marker should be placed at
center of gel while the other four markers should be positioned in way that they do not occupy
the same slice; two of these markers could be placed at the superior/inferior gel borders and
the other two could be placed on the sides of the vessel.
5.7

Calibration Curve
Calibration curves were drawn for 4 and 10 MV photon beams (Figures 4.6 and 4.7,

respectively). Data from the curve fits show the similarities between the two curves as their
chi-squared and y-intercept values are very similar (Chapter 4.5). The gel is expected to be
linear to at least 10 Gy (maximum dose delivered to gel as requested to gel manufacturer).
This data show the energy independence of the BANG-3TM gel. Dose rate independence is
also demonstrated (3.339 % R2 difference shown for gel irradiated to the same energy and
dose). However, this dose rate independence is not conclusive, as more than one
measurement should be evaluated. From here, it is concluded that the same calibration curve
can be used for gels irradiated to the 4 MV or 10 MV photon beam. In this study, an energy
of 10 MV is analyzed along with a dose rate of 400

MU
. The uncertainties are very small
min

with the largest uncertainty for the 4 MV and 10 MV beam occurring at a dose of 0 Gy.
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These results are expected as the largest % error is expected to occur at lower doses (Oldham
1998). Values for background subtraction measurements are shown in Chapter 4.5. These
values were used to compute the dose within the CGEL-S vessel
5.8

Dose Analysis
To perform dose analysis, it is imperative that all data (i.e., MRI data, Pinnacle3 dose

data and Pinnacle3 boundary data) be measured with same resolution; the measurement
resolution in this study was 0 .086 cm x 0.086 cm X 0.2 cm. These dimensions were chosen
to match the acquisition parameters of MRI. The goal of this experiment is for the
measurement error between the Pinnacle3 (ADAC) and MRI data to be within 5% of the
maximum allowable dose that can be delivered to the gel (10Gy). This deviation corresponds
to 50 cGy.
5.8.1 Image Subtraction Analysis
Image subtraction (pixel-by-pixel) was performed on the ADAC and MRI/polymer gel
images, whereby the MRI images were subtracted from the ADAC images. Global deviations
(i.e. deviations throughout the entire plane) both with and without a dose correction factor
(Chapter 4.5) were first addressed in figures 4.9-4.12. It was concluded from these figures
that scans performed 5 days post-irradiation that take the dose correction factor into
consideration show the best agreement between ADAC and MRI data. In this case, the
criteria for deviation (50 cGy) was met for nearly every slice. Local deviations (i.e.,
deviations throughout the plane within organs) both with and without correction factors were
addressed in figures 4.13-4.17. Measured and planned data within organ regions were closer
in agreement when the correction factor was taken into consideration. Negative values
correspond to higher MRI readings. Dose deviations within each organ were all within the
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tolerance value of 50 cGy: rectum (~0Gy), rt. femoral head (~-18 cGy), bladder (~-11cGy),
lt. femoral head (~-27 cGy) and prostate (~25 cGy). Almost all data show larger MRI dose
measurements than ADAC dose measurements, which is expected as the gel was exposed to
scatter and leakage radiation in treatment room for two days prior to irradiation. Figure 4.13
illustrates a problem existing in the dose correction factor, whereby near the center of the gel,
this factor overcompensated for the excess dose delivered to the gel. However, with no
correction factor, the deviations between the MRI and ADAC dose were larger. While the
dose correction factor is necessary, it must be modified in order to contribute less near the
center of the gel and more near the periphery of the gel.
As stated earlier, MRI and ADAC results were more in agreement for MRI images
taken 5 days post-irradiation as opposed to 2 months post-irradiation both with and without
the dose correction factor. The results taken 2 months post-irradiation are misleading as
proper care of the gel was not taken in the 2 month span prior to imaging (e.g., gel exposed to
sunlight and temperature was not monitored). However, these results were expected as
spontaneous polymerization continues in the gel regardless of irradiation. The rate of the
spontaneous R2 increase depends on temperature (gels kept cold will polymerize slower than
those kept warm) and is uniform throughout the gel volume. It can be concluded from these
results that it is better to analyze the gel as soon as possible after irradiation (at least 30 min).
There was an overall satisfaction with the image subtraction analysis between the MRI results
and ADAC measurements. The data more applicable to our center (i.e., 5 days postirradiation) meet deviation criteria requirements of less than 50 cGy.
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5.8.2 Contour Analysis
Qualitative analysis of dose contours within the polymer gel is shown in figures 4.184.21 at a slice located at 100 SPD (z=0). Little agreement was observed between gel data and
ADAC data. Again, MRI data taken 5 days post-irradiation more closely resembled the
ADAC data than the MRI data taken 2 months post-irradiation. The dose correction factor
was once more investigated and it was observed that when comparing the ADAC data to the
MRI data taken 5 days post-irradiation, data toward the periphery of the gel appear more
agreeable than near the center when this factor was considered and vice-versa. Again, a
modification to the dose correction factor is needed.
Figures 4.22-4.24 show the contour regions along with the organs studied in this
investigation. As with the image subtraction data and first set of contour data, MRI data were
higher than ADAC data when no correction factor was used and lower MRI doses were
observed at the center of the gel when the factor was used. An age correction factor was used
on the MRI data taken 2 months post-irradiation. This factor appears to be correct as the dose
distributions from MRI closely followed the distributions from ADAC. This procedure
confirms the theory that images from the two post-irradiation MRI scans images are different
because of the increased dose with age in the gel. The age factor thus corrects for the
increased polymerization within the gel.
The latter set of figures demonstrates the ability of the polymer gel dosimeter to
analyze dose within steep dose gradient regions. Data show contour lines for 100 cGy, 150
cGy, 180 cGy, 190 cGy and 200 cGy both for ADAC and MRI, along with the organ
boundaries. Analysis that could be made with these figures, for example, is the dose
surrounding the OAR and PTV when the correction factor is not considered. In this case, the
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ADAC and MRI contour lines for 180-200 cGy appear to closely surround/encompass the
prostate. Also, this same figure shows that the bladder and rectum receive high dose (as much
as 200 cGy) and 150 cGy dose extending out to the femoral heads. More analysis could be
made for data containing the dose correction factor and data taken two months postirradiation.
Qualitative imaging is the key for the contour analysis imaging. With better results
and less noise, the spatial deviation between the ADAC and MRI data could be measured.
Overall, IDL analysis of the contour dose and organ volume distributions throughout the gel
proved to be very reliable and should be used with quantitative analysis to provide more
validity to the results.
5.8.3 Dose-Volume Analysis
The results of the dose-volume analysis measurements are discussed in Chapter 4.7.3.
A comparison was performed between the volume of the organs for ADAC and IDL to ensure
that similar volume were being analyzed. Deviations between the two volumes were
determined to be very small.
Figures 4.25 and 4.26 represent the ratios contain ratios of the total dose per volume
measured (cm3) by MRI to total dose per volume (cm3) within each plane with and without
the dose correction factor. An ideal value in this instance would be one, as this would suggest
identical dose per volume for ADAC and MRI. This analysis once again shows an
overcompensation for the excess dose near the center of the gel (180 cGy to 200 cGy) and the
reverse effect near the periphery of the gel (100 cGy). The 150 cGy region benefits most
from the correction factor as the ratio is nearly unity throughout the gel. All regions are
higher for MRI than ADAC when the dose correction factor is not considered. Once again an
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argument here can be made about the necessity for the dose correction factor with
modifications.
Maximum dose values per plane (Figure 4.27) also show the need for the dose
correction factor as data with correction factor clearly agreed better with ADAC
measurements than data without the correction factor. This figure also shows that, as
expected, the excess dose due to leakage and scatter radiation was delivered mainly to the
gel’s outer regions; towards the periphery, the MRI dose is higher than the ADAC dose even
when the corrections factor is considered.
Dose volume histograms for ADAC and MRI are shown in figures 4.28-4.30. Aside
from the prostate, the DVH utilizing the dose correction factor is more in agreement to the
ADAC-DVH than the figure without the dose correction factor. The dose correction factor
lowers the measured dose by MRI hence the reason that the DVH drops off for the prostate
around 150 cGy. Neither DVH would be acceptable at MBPCC as the PTV receives too little
dose in figure 4.28 and the OAR receive too high of a dose in figure 4.29. At MBPCC, a
desired dose for the PTV is at least 95 % of the prescription dose. In the case of the prostate
190 cGy is optimal dose for the entire volume of the prostate as 200 cGy was the prescription
dose. An ideal dose for the OAR is that no more than 50 % of their total volume receives a
dose above 100 cGy; this tolerance is clearly exceeded in both MRI-DVHs. The MRI-DVH
without the correction factor for the prostate is in better agreement with the ADAC-DVH than
is the MRI-DVH with the dose correction factor (i.e., the entire prostate volume receives 185
cGy, which is pretty close to the desired value of 190 cGy). This data show that a correction
factor must be used to account for the excess dose delivered to the polymer gel due to
leakage/scatter radiation, but a modification to this factor is necessary.
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5.9

Clinical Outlook at MBPCC
With IMRT and other novel radiotherapy techniques (e.g., SRS and prostate

brachytherapy), MBPCC would greatly benefit from the use of the BANG-3TM polymer gel.
To implement the gel dosimetry technique, MBPCC would first need to establish contacts
with a gel manufacturing company (MGR Research, Inc.) and a gel analysis service (Stony
Brook). All other equipment necessary for type of dosimetry is at hand at MBPCC. The
following steps would need to be taken in order to perform the gel dosimetry technique for
IMRT procedures (per patient)
1). Purchase one CGEL-S vessel, *8 calibration vials (minimum order). Gels can be
manufactured to fit specific dose requirements (e.g., maximum dose received by
gel). Arrival of gel should take place two days prior to irradiation so that gel can
equilibrate to temperature of the cancer center.
Keep shipment box and ice coolers for future shipments (see number 7).
2). Store gel away from blue light and ultraviolet light in room with a temperature in
the range of 64-72 ˚F. Calibration gel and experimental gel should be kept at
same environmental conditions.
3). Obtain x-ray CT scans of the BANGTM gel
4). Place the CGEL-S vessel on the treatment table and deliver the planned treatment
MU
to the gel. Use no more than 400
.
min
5). Place calibration vial on bottom of cubic water tank at CAX and deliver necessary
doses for calibration curve. Doses delivered can be anywhere from 0 Gy to
maximum allowable dose that the gel can receive (see number 1).
6). Perform any dose verification procedures (e.g., ionization chamber measurement
and film QA) if desirable.
7). **Scan the CGEL-S vessel and calibration vials. See Table 3.8 for scanning
parameters. Gels must be sent to scanner at least two days prior to scan. Can also
ship gel to scanning service (Stony Brook) where results can be obtained in 3-4
days.
8). Analyze data from scans. Analysis can be done by an in-house method (e.g., IDL,
Dose3-D QA) or by the gel scanning service.
9). Return gel to manufacturer when analysis completed.
*

Because gel is independent of dose rate and temperature, the same calibration curve can be
used for all photon beams specific to that machine.
**
An MRI scan can be done prior to irradiation to account for background subtraction.
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Small steps should first be taken to establish the BANG-3TM dosimetry at MBPCC in
an effort to reduce manpower issues in using the technique. For example, one suggestion
would be to limit the gel service to new sites treated or use gel once per month. This would
allow the department to gain experience into using this new system, and at the same time, find
a way to integrate the polymer gel technique with the current method used (film-based QA).
Also, a judgment can be made into the usefulness and reliability of the gel. A second
suggestion would be to use the scanning service. In this case, all that would be required of the
physicists is the purchase, storage and irradiation of the gel and shipment to the scanning
company.
5.10

Conclusion
All in all, we were very impressed with the capabilities of what the polymer gel can

do; it allows one to analyze and compare planned dose and measured dose in 3D. The dose
deviation can be analyzed and examined for any organ of interest. The measurement
(absolute) error aimed for was 5 % of 10 Gy or 50 cGy. This amount was maintained for all
images taken 5 days post-irradiation that take into account the dose correction factor. The
relative error depends upon the dose delivered to the gel. The relative error increases as the
total dose delivered to the gel decreases. In this case, the total dose delivered was 2 Gy, thus
the relative error was high. Looking at the situation 5 days post-irradiation with the
correction factor this error was as high as 28.5% for global image subtraction analysis and for
image subtraction within the organs was as high as 15 % (left femoral head).
Using the data from the 10 MV R2 -dose calibration curve and the 10 MV fitting
parameters (Table 4.4) along with the equation in Chapter 3.6.8, we computed a relative error
of 9.2% with a gel irradiation of 10 Gy. The relative error was smaller than the value
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obtained with a gel irradiation of 2 Gy, 25%. Though the percent error was larger than the
anticipated error of 5%, this decrease was promising for this study as the error dropped to a
reasonable value.
The noise levels were very plentiful with the MRI analysis. Noise estimations were
approximated from IDL analysis to be 1% in proton density MR data and 1.3 % for T2 data,
corresponding to a total amplifying noise of 1.6 %. Noise can potentially be reduced by using
the full dynamic range of the gel; would increase the SNR. Also, more acquisitions and
signal averaging could be performed when scanning via the MRI scanner. A downfall to
these increased acquisitions is an increase in scanning time.
Aside from the excess radiation received by the gel, other procedural errors were
present. For instance, the fiducial markers were not placed at an optimal position to locate the
superior/inferior edges of the CGEL-S vessel. Suggestions to the placement of these markers
can be found in Chapter 5.6. Also, as can be seen in figures 4.22 and 4.23, the gel was not
masked properly to eliminate regions outside of the gel (e.g.. high dose regions at perimeter of
gel). This error occurred at the periphery of the gel, thus did not affect the results. The image
was kept to demonstrate errors/other data that may be present in analysis.
Finally, as the CT is more accessible to MBPCC than the MRI scanner, some
questions may arise as to the use of CT for scanning the gel as opposed to MRI. As stated in
Chapter 2.3.3, though x-ray CT has proven to be accurate and capable of localizing high dose
gradients, this scanning method has a lower dose resolution and a greater dose uncertainty.
This technique may be more developed in the future and when it is, MBPCC should
reevaluate x-ray CT’s usefulness in polymer gel analysis.
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Chapter 6
Conclusion
With the recent advances of radiotherapy treatment techniques at MBPCC, a 3D
dosimetry technique was analyzed for its feasibility, precision and accuracy. The dosimetric
system was based on the BANG-3TM polymer gel. This gel was analyzed for its effectiveness
in quantifying the 3D dose distribution produced by an IMRT treatment. The plan for this
treatment was produced by a Pinnacle3 treatment planning computer, whereby measured dose
distributions determined from the polymer gel were compared to the calculated planned data.
The PTV within the treatment was the prostate and the OAR were the femoral heads, rectum
and bladder; a 7 field treatment technique was applied.
The polymer gel was purchased in a plastic cylindrical vessel and glass calibration
vials. The vessel was used to map out the 3D dose distribution from the irradiation, while the
vials were used to calibrate the vial response R2 to the absorbed dose (Gy). A calibration
curve was generated and used to determine the dose within the polymer gel. Vials were
calibrated to different energies and different dose rates to test for an energy/dose rate
dependence of the gel. The gel was found to be independent of both energy and dose rate.
A historical overview of gel dosimetry was discussed in detail. In this section, the two
types of dosimeter systems used (e.g., polymer gels and Fricke gels) were discussed. In
particular, research involved with these dosimetry systems was analyzed and the systems were
compared. Also, other types of gel imaging systems were reviewed (e.g., optical-CT, x-ray
CT and ultrasound), along with clinical uses of the polymer gel (e.g., SRS and
brachytherapy). The materials used in this study and the methods involved with their use
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were analyzed. In this case, technical specifications involved with the polymer gel, MRI,
Pinnacle3 planning software, IMRT treatment delivery and IDL procedures were discussed.
Other dosimetric techniques were performed to test the validity of the distributions
produced within the gel. In particular, ionization chamber measurements were compared to
Pinnacle3 measurements on a point-by-point basis and film was used to compare planar dose
distributions. All measurements met acceptance criteria and it was concluded that the planned
dose and delivered dose were in agreement.
All scanning was performed by an MRI located at OLOLRMC. The scanner produced
3D images in the form of T2 -weighted and proton density weighted images that were
combined to compute the relaxation rate ( R2 ). Images were produced in multiple planes and
were compared to the Pinnacle3 dose values pixel-by-pixel using a commercial dataprocessing package (IDL). Scans were performed 5 days post-irradiation and 2 months postirradiation.
Before analysis began, several steps were applied to assure that the Pinnacle3 and gel
dose distributions were aligned. These steps included shifts, rotations and adjustments in
pixel size. The pixel size used was 0.086 cm x 0.086 cm x 0.2cm. Three types of
comparisons were done with the IDL system: image subtraction, dose-volume analysis and
contour comparisons. Each method provided excellent analysis into the deviations between
the calculated Pinnacle3 dose distributions and the measured gel dose distributions. The
image subtraction and dose analysis provided global analysis (i.e., throughout plane) and local
analysis (i.e., throughout plane and within organ). Also, the dose analysis provided a
comparison between the maximum dose received per plane for the Pinnacle3 system and MRI.
Contour analysis provided a qualitative analysis of the dose distributions of both Pinnacle3
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and CT data; some figures contained the organs of interest and others did not. A dose
correction factor was presented as the gels were erroneously exposed to scatter and leakage
radiation prior to gel irradiation. All data indicated that the best results occurred for the scans
taken 5 days post-irradiation when the dose correction factor was taken into consideration. In
this case, nearly all data met the expected measurement error of 5 % of the maximum dose
(50 cGy). Relative errors were determined to decrease from 25% at a 2 Gy irradiation to
9.2% for a 10 Gy irradiation.
The BANG-3TM polymer gel dosimetry system proved to be an invaluable method for
the quantification of the 3-D dose distribution provided by IMRT. A measurement error of
less than 5 % was achieved. This technique is suggested for use at MBPCC in performing the
QA for an IMRT treatment in three dimensions. Cost, manpower issues, toxicity and
uncertain response to particular environmental characteristics (i.e., temperature and aging)
upon the gel are concerns about the use of the gel at this time. However, more
experimentation is being done to investigate gel response; gel handling could be kept to a
minimum due to the availability of a reliable gel manufacturer (MGS Research, Inc.) and a gel
scanning service (Stony Brook). A decrease in cost with increased clinical use will soon put
these concerns to rest.
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Appendix A
Pinnacle3 Treatment Plan
Appendix A provides a summary of the treatment plan used to irradiate the gel.
Technical information such as the beam setup parameters, prescription dose, isocenter
position and beam geometries are contained within this section.
A.1

Patient Data
Patient Name: New, New
Patient ID: A000000
Plan Name: Gel
Trial Name: Trial 1
Date/Time: Mon. September 23, 2002/14:45:18
Institution: Mary Bird Perkins Cancer

A.2

Plan Summary Sheet

Beam Setup
Machine-Clinac 21EX
Energy-10 MV
Modaility-Photons
Table A.1 Setup parameters for the various beams used to irradiate the polymer gel. Shown
are the seven different beams used, their respective SSDs and the MU per fraction delivered
from each beam.
Beam
Start/Avg. SSD (cm)
MU per fraction
RPO 295
91.70/91.70
37
Rt. Lat. 265
91.60/91.60
60
RAO 225
91.46/91.46
47
AP 180
91.28/91.28
100
LAO 135
91.25/91.25
57
Lt. Lat 90
91.33/91.33
66
LPO 65
91.45/91.45
36
Table A.2 Collimator, gantry and couch setup for the seven irradiation beams used to irradiate
the polymer gel. Shown are the collimator positions, gantry start and stop angles, couch and
collimator angles and the block type.
Beam
X1/X2 (cm)
Y1/Y2 (cm)
Gantry
Couch/
Block
Start/Stop
Collimator
RPO 295
4.5
3.0
295/295
180/180
MLC
Rt. Lat 265
4.5
3.0
265/265
180180
MLC
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Table A.2 cont’d.
RAO 225
AP180
LAO 135
Lt. Lat 90
LPO 65

4.5
4.5
4.5
4.5
4.5

3.0
3.0
3.0
3.0
3.0

225/225
180/180
135/135
90/90
65/65

180/180
180/180
180/180
180/180
180/180

MLC
MLC
MLC
MLC
MLC

Prescription
Prescribe 200 cGy per fraction to 100% of dose at “iso” for 35 fractions.
Beam weights are proportional to point dose.
Actual dose at “iso” from all prescriptions beams is 7027.83 cGy.
7 beams are assigned to this prescription.
Isocenter
Iso
Position patient such that lasers line up with patient marks.
Move the table LEFT 0.46 cm (looking from foot of table.)
Move the table UP 1.67 cm
Move the table IN (toward the gantry) 1.05 cm.
Plan Setup
Data Set Name: PAULS PROJ
Data Set Dimensions: 54 slices, 512 X 512 pixels
CT to Density Table Name: MBPCC
Patient Position On back (supine) Head First
Couch: Removed at Y=-9.91
Body Board Angle: None
Number of Photon Beams: 7
Number of Stereo Beams: 0
Number of Electron Beams: 0
Number of Brachy Sources: 0
Outside-Patient Air Threshold: 0.60g/cm^3
Top Slice of CT Extended: 0.00cm
Bottom Slice of CT Extended: 0.00cm
Region of Interest Overrides: No ROI density overrides in use.
Table A.3 This table contains the dose grid geometry used in the treatment. Contained within
the table is the resolution, dimension and origin at the Lateral, Ant-Post and Sup-Inf positions.
Lateral
Ant-Post
Sup-Inf
Units
Resolution
0.400
0.400
0.400
cm
Dimension
47
46
28
Pixels
Origin
-8.783
-10.423
-4.119
cm
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Dose
Dose Engine: Adaptive Convolve
Density Correction: Heterogeneous
Reference Point: iso
Collimator Output Factor (OFc): 0.990
MLC Transmission Factor: 0.0440
Total Transmission Factor (TTF):1.000
SPD/OAD (cm):100.00/0.00
Number of Fractions: 35
Table A.4 Dose parameters for the seven fields are shown in this table. Data includes the
relative weight for each beam, the normalized dose at the reference point, the reference point
depth/the effective depth, the equivalent square of the unblocked region along with the
percentage that it blocked and the dose delivered to the reference point per fraction.
Dose at
Unblk Equiv
Ref Pt
Beam
Relative
Normalized
Ref/Fraction
Sq cm/%
Depth/Eff
Weight (%) Dose at Ref
(cGy)
Blkd
Depth (cm)
Pt
RPO 295
14.90
0.922
8.30/8.58
7.2/53.2%
30.2
Rt. Lat.265
7.50
0.283
8.40/8.67
7.2/46.4%
15.0
RAO 225
19.40
0.938
8.54/8.84
7.2/89.8%
39.0
AP 180
16.20
0.366
8.72/9.02
7.2/86.1%
32.4
LAO 135
19.70
0.781
8.75/9.04
7.2/84.7%
39.4
Lt. Lat.90
7.50
0.258
8.67/8.96
7.2/48.2%
15.1
LPO 65
14.80
0.933
8.55/8.84
7.2/68.1%
29.7
Point of Interest Dose Information
Trial Name: Trial_1
Absolute Maximum Dose: 7656.33 cGy at 2.42, 0.38, -0.52
Trial_1, iso
(Lateral, Ant-Post,Sup-Inf) = (0.44, -1.70, 0.15) cm
Table A.5 The absolute dose (cGy) and the weighting factor for each beam in the irradiation
are shown in this table. (The amount shown is for 35 fractions.)
Beam
Abs Dose (cGy)
Pct
RPO 295
1056.36
15.0%
Rt. Lat. 265
526.18
7.5%
RAO 225
1364.90
19.4%
AP 180
1134.56
16.1%
LAO 135
1378.79
19.6%
Lt. Lat. 90
527.20
7.5%
LPO 65
1039.84
14.8%
Total
7027.83
100.0%
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Region of Interest Dose Statistics
Table A.6 This table contains dose statistics to the regions of interest within the irradiated
polymer gel. Shown in the table are the regions of interest along with their volume,
minimum, maximum and mean values of the dose received and the standard deviation of the
dose. Units are in cGy.
ROI
Volume(cm^3) Min
Max
Mean
Std.
Units
%
Value
Value
Value
Dev.
outside
volume
Prostate 45.5489
6257.4
7616.89 7091.09 98.0561 cGy
0.00%
Lt.
15.4014
2105.7
5131.85 3398.73 588.644 cGy
0.00%
Femoral
Rt.
11.4029
1874.64 5077.09 3246.62 630.134 cGy
0.00%
Femoral
Bladder 57.7522
1629.04 7433.86 4191.36 1332.77 cGy
0.00%
Rectum 36.241
1056.02 7165.08 3393.58 1657.9
cGy
0.00%
Ring
717.644
0
6008.06 2395.7
1070.03 cGy
0.00%
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Appendix B
IDL Programming Codes
This appendix contains the various IDL programs and routines used throughout this
study in order to analyze the polymer gel and compare the dose distribution from the ADAC
planning computer and the MRI/gel. Also contained in this appendix are the various programs
written prior to analysis in which rotations and shifts were performed.
B.1 Read_PlanROI
PRO Read_PlanROI, SLICE2SHOW = slice2show, PRINT=print, SAVE=save
;reads in region of interest (boundary data) and performs routines upon these parameters
;beginning lines used to read in boundary file and defines cindex and regiontemp
ROIfile = 'plan.roi' ;defines ROIfile
;red, green, blue, yellow, purple, lavendar (approximately)
colors = [ 255L, 255L*256L, 255L*256L^2, 255L*256L+255L*256L^2, $
255L+255L*256L^2, 255L+127L*256L^2 ]
cindex = 0
regiontemp=bytarr(256,256) ;matrix size identical to MRI matrix
IF NOT KEYWORD_SET( slice2show ) THEN slice2show = 0
;set up the plotting window
PLOT, [0,0], XRANGE=[-14,14], YRANGE=[-14,14], TITLE='100SPD', /NODATA, $
XSTYLE=1, YSTYLE=1
OPENR, inLUN, ROIfile, /GET_LUN ;open file, allocate LUN
REPEAT BEGIN ;until end of file
; #=#=#=#=#=# looking for the ROI name
readstring = ''
searchstring = 'name: '
searchlength = STRLEN( searchstring )
REPEAT BEGIN
READF, inLUN, readstring
p = STRPOS( readstring, searchstring )
ENDREP UNTIL ( p NE -1 )
;extract the ROI name
ROIname = STRCOMPRESS( STRMID( readstring, p+searchlength ), /REMOVE_ALL )
; #=#=#=#=#=# looking for the number of curves
searchstring = 'num_curve = '
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searchlength = STRLEN( searchstring )
REPEAT BEGIN
READF, inLUN, readstring
p = STRPOS( readstring, searchstring )
ENDREP UNTIL ( p NE -1 )
READS, STRMID( readstring, p+searchlength ), ncurves, FORMAT='( I, ";" )'
ncurves = FIX( ncurves )
;this array stores the area contained in each region
area = FLTARR( ncurves )
region3D=bytarr(256,256,ncurves)
sliceorder=intarr(ncurves)
FOR i = 0, ncurves - 1 DO BEGIN
; #=#=#=#=#=# looking for the number of points
searchstring = 'num_points = '
searchlength = STRLEN( searchstring )
REPEAT BEGIN
READF, inLUN, readstring
p = STRPOS( readstring, searchstring )
ENDREP UNTIL ( p NE -1 )
READS, STRMID( readstring, p+searchlength ), npoints, FORMAT='(I,";")'
npoints = FIX( npoints )
;read the next (garbage) line. If we wanted to error-check, it
READF, inLUN, readstring ; should be "points={"
;allocate array and temp variables
ROIdata = FLTARR( 2, npoints ) ;x is dim 0, y is dim 1
x = 0.0 & y = 0.0 & z = 0.0
;read the x,y,z data points
FOR j = 0, npoints - 1 DO BEGIN
READF, inLUN, x, y, z
ROIdata[*,j] = [x, y]
ENDFOR ;npoints
;end of file reading
;converts z number into integer value then defines sliceorder
slice_num = ROUND( z / 0.3 )
sliceorder(i)=slice_num
;converts from cm to pixel indexes
ROIdatap=FLOOR(ROIdata/0.0859375);same pixel size as dose data
;shift center so center at same coordinate at center of ADAC dose
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ROIdatap[0,*]=ROIdatap[0,*]+123
ROIdatap[1,*]=ROIdatap[1,*]+148
;saves boundary information
; IF ( slice_num EQ 0) THEN BEGIN
; outfile = ROIname + STRCOMPRESS(npoints,/remove)
; OPENW, outLUN, outfile, /GET_LUN
; WRITEU, outLUN, ROIdatap
; FREE_LUN, outLUN
; ENDIF
;fills in boundaries
indexes=Polyfillv(roidatap[0,*],roidatap[1,*],256,256) ;gives region pixels in terms of MRI
matrix size
regiontemp(*)=0b;reinitalize array
regiontemp(indexes)=1b;value of 1 means point is in region
region3D(*,*,i)=regiontemp
;compute the area contained within this region
area[i] = poly_area( roidata[0,0:npoints-2], roidata[1,0:npoints-2] )
IF ( slice_num EQ slice2show ) THEN BEGIN ;plots the organ regions
OPLOT, ROIdata[0,*], ROIdata[1,*], THICK=5, COLOR=colors[cindex]
XYOUTS, ROIdata[0,0], 0.2 + ROIdata[1,0], $
STRUPCASE( ROIname ), CHARSIZE = 2, CHARTHICK=2, $
ALIGNMENT = 0.5, COLOR = colors[ cindex ]
; IF ( ROIname EQ 'prostate' ) THEN $
; POLYFILL,ROIdata, color = colors[ cindex ] ;fills in contours
ENDIF
;the following lines are for guess-timating pixel size
;diff = FLTARR( npoints - 2 )
;FOR j=0,npoints-3 DO diff[j] = ABS( roidata[1,j] - roidata[1,j+1] )
;IF KEYWORD_SET( print ) THEN $
;PRINT, ROIname, slice_num, npoints, $
;AVERAGE( diff[ WHERE( diff NE 0.0 ) ] ), ' cm/pixel'
ENDFOR ;ncurves
print,sliceorder
sliceorder=sort(sliceorder) ;returns subscripts in ascending order
print,sliceorder
region3D=region3D(*,*,sliceorder) ;redefines 3D function with corrected slice order
;the following lines of code copies data from 3mm slices into 2mm slices to be used in DVH
and image subtraction analysis
new3D=bytarr(256,256,16)
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IF ( ROIname EQ 'prostate' OR ROIname EQ 'bladder') THEN begin
;new slice 0-2 and 14-15 contain no prostate or bladder
new3D(*,*,3)=region3D(*,*,0) ;new slice at -0.8cm
new3D(*,*,4)=region3D(*,*,1) ;new slice at -0.6cm
new3D(*,*,5)=region3D(*,*,1) ;new slice at -0.4cm
new3D(*,*,6)=region3D(*,*,2) ;new slice at -0.2cm
new3D(*,*,7)=region3D(*,*,3) ;new slice at 0.0cm
new3D(*,*,8)=region3D(*,*,3) ;new slice at 0.2cm
new3D(*,*,9)=region3D(*,*,4) ;new slice at 0.4cm
new3D(*,*,10)=region3D(*,*,5) ;new slice at 0.6cm
new3D(*,*,11)=region3D(*,*,5) ;new slice at 0.8cm
new3D(*,*,12)=region3D(*,*,6) ;new slice at 1.0cm
new3D(*,*,13)=region3D(*,*,7) ;new slice at 1.2cm
outfile = ROIname + '_2mm.roi'
OPENW, outLUN, outfile, /GET_LUN
WRITEU, outLUN, new3D
FREE_LUN, outLUN
ENDIF
IF ( ROIname EQ 'ltfemoral' OR ROIname EQ 'rtfemoral') THEN begin
;new slice 0-2 and 11-15 contain no femoral heads
new3D(*,*,3)=region3D(*,*,0) ;new slice at -0.8cm
new3D(*,*,4)=region3D(*,*,1) ;new slice at -0.6cm
new3D(*,*,5)=region3D(*,*,1) ;new slice at -0.4cm
new3D(*,*,6)=region3D(*,*,2) ;new slice at -0.2cm
new3D(*,*,7)=region3D(*,*,3) ;new slice at 0.0cm
new3D(*,*,8)=region3D(*,*,3) ;new slice at 0.2cm
new3D(*,*,9)=region3D(*,*,4) ;new slice at 0.4cm
new3D(*,*,10)=region3D(*,*,5) ;new slice at 0.6cm
outfile = ROIname + '_2mm.roi'
OPENW, outLUN, outfile, /GET_LUN
WRITEU, outLUN, new3D
FREE_LUN, outLUN
ENDIF
IF ( ROIname EQ 'rectum') THEN begin
new3D(*,*,0)=region3D(*,*,0) ;new slice at -1.4cm
new3D(*,*,1)=region3D(*,*,1) ;new slice at -1.2cm
new3D(*,*,2)=region3D(*,*,1) ;new slice at -1.0cm
new3D(*,*,3)=region3D(*,*,2) ;new slice at -0.8cm
new3D(*,*,4)=region3D(*,*,3) ;new slice at -0.6cm
new3D(*,*,5)=region3D(*,*,3) ;new slice at -0.4cm
new3D(*,*,6)=region3D(*,*,4) ;new slice at -0.2cm
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new3D(*,*,7)=region3D(*,*,5) ;new sliec at 0.0cm
new3D(*,*,8)=region3D(*,*,5) ;new slice at 0.2cm
new3D(*,*,9)=region3D(*,*,6) ;new slice at 0.4cm
new3D(*,*,10)=region3D(*,*,7) ;new slice at 0.6cm
new3D(*,*,11)=region3D(*,*,7) ;new slice at 0.8cm
new3D(*,*,12)=region3D(*,*,8) ;new slice at 1.0cm
new3D(*,*,13)=region3D(*,*,9) ;new slice at 1.2cm
new3D(*,*,14)=region3D(*,*,9) ;new slice at 1.4cm
new3D(*,*,15)=region3D(*,*,10) ;new slice at 1.6cm
outfile = ROIname + '_2mm.roi'
OPENW, outLUN, outfile, /GET_LUN
WRITEU, outLUN, new3D
FREE_LUN, outLUN
ENDIF
;saves boundary file data
IF KEYWORD_SET( save ) THEN BEGIN
outfile = ROIname + '_2mm.roi'
OPENW, outLUN, outfile, /GET_LUN
WRITEU, outLUN, region3D
FREE_LUN, outLUN
ENDIF
;prints info if print keyword is used
IF KEYWORD_SET( print ) THEN $
PRINT, ROIname, ' has volume of ', 0.3 * TOTAL( area ), ' cm^3'
;read three more lines to get to the end of this ROI stanza
READF, inLUN, readstring
READF, inLUN, readstring
READF, inLUN, readstring
cindex = cindex + 1 ;increment the color index for the next ROI
ENDREP UNTIL EOF( inLUN )
FREE_LUN, inLUN ;close file, deallocate LUN
END
B.2 Difference
Pro difference,filename1,filename2,input1,input2
;performs analysis: image subtraction, dose volume analysis and contour analysis
;mask procedure used to eliminate regions outside gel region
mask=bytarr(256,256)
for x=0L,255 do $
for y=0L,255 do begin
temp =(x-127)^2+(y-124)^2
if (temp LE 93L^2) then mask[x,y]=1
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endfor
indexes=where(mask EQ 1)
con3D=bytarr(256,256,16)
;opens mr dose file
openr,1,'dose/'+filename1+'.dose1'; filename1 is sub1,sub2,nosub1,nosub2
mrdose=fltarr(256,256,70)
readu,1,mrdose
close,1
;mrdose=reverse(mrdose,2) ;rotates image in y plane
;opens ADAC dose file
openr,1,'/home/paul/ADACdose/'+filename2;filename 2 is QAbeam94.4SPD-QAbeam104.4SPD
str=''
for i=0,10 do begin readf,1,str
endfor
adose=fltarr(256,256)
temp=fltarr(256)
x=fltarr(256)
readf,1,x,format='(",",256(f0.3,","))'
y=0.0
for i=0,255 do begin readf,1,y,temp,format='(f0.3,256(f0.3,","))'
adose[*,i]=temp
endfor
;adose=reverse(adose,2) ;rotates image in y plane
; use next lines of code for image subtraction
;;oname=['prostate','ltfemoral','rtfemoral','bladder','rectum']
;;onum=[253,185,151,335,230]
;;For i=0,4 do Begin
;;con3D=bytarr(256,256,16)
;;openr,5,'/home/paul/boundaries/'+oname(i)+'_2mm.roi';+STRCOMPRESS(onum(i),/remove
) ;opens boundary file
;;readu,5,con3D
;;close,5
openr,2,'/home/paul/boundaries/'+'rectum'+'_2mm.roi'
readu,2,con3D
close,2
;;want to subtract at -0.8,-0.6,...,1.2 cm for bladder and prostate
;;correspond to 100.8 SPD to --98.8 SPD
indexesa=Where(con3D(*,*,input2) EQ 1b)
;diff=fltarr(256,256)
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;diff=(adose[indexesa])-((mrdose(*,*,input1))[indexesa]) ;input1 is 0--50 ;input2 is 015
;print,average(diff)
;print,stddev(diff)
; use next 6 lines to determine maximum dose for ADAC and MRI
;max=max(adose[indexesa]) ;defined by filename2
;print,max
;max=max((.765*mrdose(*,*,input1))[indexesa]) ;defined by number used for input, takes
into account dose correction factor
;print,max
;max=max((mrdose(*,*,input1))[indexesa]) ;defined by number used for input, does not take
into account dose correction factor
;print,max
;use next several lines of code for contour analysis
;!x.style = 1 ;sets x-axis to exact range
;!y.style = 1 ;sets y-axis to exact range;115L+75*256L^2
;color =
[255L+255*256L+255*256L^2,127L*256L,120*256L+180L*256L^2,127L+96*256L+30*2
56L^2,60L+127L*256L^2]
;oname=['prostate','ltfemoral','rtfemoral','bladder','rectum']
;onum=[253,185,151,335,230]
;PLOT, [0,0], XRANGE=[0,255], YRANGE=[0,255], TITLE='100SPD', /NODATA
;For i=0,4 do Begin
; temp=lonarr(2,onum[i])
; openr,5,'/home/paul/boundaries/'+oname(i)+STRCOMPRESS(onum(i),/remove) ;opens
boundary file
; readu,5,temp
; close,5
;OPLOT, temp[0,*], (temp[1,*]), THICK=0 ;, COLOR=color[i]
; POLYFILL,temp,color=color[i]
;ENDFOR
; color = [135L+255L*256L^2,255*256L,255+255L*256L,255*256L+255L*256L^2,255L]
;sets colors for contour lines
; level=[1,100,150,180,190,200] ;sets contour levels
; contour,smooth(mrdose(*,*,input),5),level=level,c_color=color,/noerase;1.735 correction for
2 months post-irradiation
; contour,adose,level=level,c_linestyle=[2,2,2,2],c_color=color,/noerase
;next 4 line of code are for determining number of pixels that contain a particular dose within
gel
FOR d=0,5 DO BEGIN
print,level(d)
print,n_elements(where(adose[indexesa] GE
level(d))),n_elements(where((.765*mrdose(*,*,input1))[indexesa] GE
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level(d))),n_elements(where((mrdose(*,*,input1))[indexesa] GE level(d)))
ENDFOR
; conplot=tvrd(/true)
; write_jpeg,'contour2.jpg',conplot,/true ;saves image as a jpeg file
;use next lines for color contouring
;loadct,12 ;loads color table
;max=max(.765*mrdose(*,*,input))
;restore,'myct.save' ;restores color table
;tvlct,r,g,b
;tv,bytscl(smooth(.765*mrdose(*,*,input),3),min=0,max=220),0
;tv,bytscl(adose,min=0,max=220) ;,1
;color table used (saved in a file)
;r(0)=0
;g(0)=0
;b(0)=0
;r(0:174)=0
;r(175:209)=120
;r(210:255)=255
;g(0:174)=120
;g(59:116)=255
;g(175:232)=0
;g(245:255)=255
;b(0:58)=0
;b(59:116)=120
;b(117:209)=255
;b(210:220)=120
;b(221:232)=0
;b(233:244)=220
;b(245:255)=255
;write statements are used to write output to file; later transferred to email
;write_tiff,'colorcontour3.tif',bytscl(smooth(.765*mrdose(*,*,input),5),min=0,max=220),red=
r,green=g,blue=b
;write_tiff,'contour.tif',bytscl(adose,min=0,max=220),red=r,green=g,blue=b
;write_jpeg,'colorcontour.jpg',mrdose(*,*,input),red=r,green=g,blue=b
close,1 ;closes ADAC dose file
end
B.3 SPD Dose
Function SPDdose,filename ;opens and reads ADAC SPDdose information
openr,1,'/home/paul/ADACdose/'+filename ;opens file
str='' ;accounts for words at beginning of file
for i=0,10 do begin readf,1,str ;reads in first 10 lines of data
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endfor
b=fltarr(256,256)
temp=fltarr(256)
x=fltarr(256)
readf,1,x,format='(",",256(f0.3,","))' ;reads in additional data
y=0.0
for i=0,255 do begin readf,1,y,temp,format='(f0.3,256(f0.3,","))'
b[*,i]=temp
endfor
;following lines were used to develop contours for the regions then saved the contours
;contour,b
;MIN_CURVE_SURF smooths contours
;CONTOUR, b,C_COLORS = [100,150,200]
;openw,1,'filename' ;opens file
;writeu,1,b
;close,1
return,b ;returns b to be used in idl
close,1 ;closes file
end
B.4 Average
;+
; NAME:
; AVERAGE
; PURPOSE:
; This function receives an array and returns the average of that array.
; For multi-dimensional arrays, a single value representing the average
; of all elements, is returned, if DIM is not set; if DIM is set, then
; the result is an array of one less dimension, containing the averages
; over the eliminated dimension.
; CATEGORY:
; Math function.
; CALLING SEQUENCE:
; AVERAGE( array [, dim] )
; INPUTS:
; array = An array of values (can be multi-dimensional) to be averaged.
; OPTIONAL INPUT PARAMETERS:
; dim = the dimension of the array to average over. DIM must, of course,
; be greater than zero.
; KEYWORDS:
; None.
; OUTPUTS:
; The average (a single numerical value) of the input array, if DIM was
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; not set, or an array (with one less dimension than the original) of
; averages if DIM was set.
; OPTIONAL OUTPUT PARAMETERS:
; COMMON BLOCKS:
; None.
; SIDE EFFECTS:
; None known.
; RESTRICTIONS:
; None known.
; PROCEDURE:
; all of any-D array: average_value = AVERAGE( array ).
; part of any-D array: average_value = AVERAGE( array(a:b,c:d,e:f,...) ).
; over a dimension D of array: average_value = AVERAGE( array, d )
; MODIFICATION HISTORY:
; Created by Kenneth Matthews, June 1992.
;;-----------------------------------------------------------------------------; function AVERAGE
;-----------------------------------------------------------------------------FUNCTION AVERAGE, array, dim
; If DIM is not set, return the average for the entire array.
IF N_ELEMENTS( dim ) LE 0 THEN RETURN, TOTAL( array )/N_ELEMENTS( array ) $
; If DIM is set, but not greater than zero, default to computing the
; average for the entire array.
ELSE IF dim LE 0 THEN RETURN, TOTAL( array )/N_ELEMENTS( array ) $
; If DIM is set, and greater than zero, then compute the averages over
; the specified dimension of the array.
ELSE BEGIN
sz = size( array )
IF dim LE sz(0) THEN RETURN, TOTAL( array, dim )/sz( dim ) $
ELSE BEGIN
PRINT, 'Value exceeds array size (', $
STRCOMPRESS( STRING( sz(0) ) ),' dimensions ).'
PRINT, 'Defaulting to average for entire array.'
RETURN, TOTAL( array )/N_ELEMENTS( array )
ENDELSE
ENDELSE
END
B.5 Compute 3DR2
Pro Compute3DR2,filename ;computes R2 values within calibration vials
nslice=37 ;number of slices to be analyzed; nslice changes depending on which file being
analyzed
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openr,1,'3D/'+filename+'.T2' ;opens T2 file
img3Da=intarr(256,256,nslice)
readu,1,img3Da
close,1
openr,1,'3D/'+filename+'.pd' ;opens proton density file
img3Db=intarr(256,256,nslice)
readu,1,img3Db
close,1
;echo times used with MRI
TE2=116
TE1=21.8
;computes R2
R2=fltARR(256,256,nslice) ;variable for final R2 values
R2[*] = 0 ; initializes array
temp = fltARR(256,256,nslice) ; working variable during calculations
temp[*] = 0 ;initializes
indexes = Where(img3Da NE 0, count) ; excludes zero in denominator
temp[indexes] = float(img3Db[indexes])/img3Da[indexes] ; proton density/T2
indexes = Where(temp GT 1, count) ; excludes negative results from ln
R2[indexes]=(alog(temp[indexes])/(TE2-TE1))*1000 ;calculate R2 at valid points
;print,R2(*,*,7) ;used to view slices of interest
;used when determining average values and standard deviations between slices
ave=fltarr(3)
std=fltarr(3)
;plotted image to be used to locate vial boundaries and center of gel
For i=0,2 Do begin
tvscl,img3Db[*,*,i+1]
getxy,x,y
;3X3 pixel region of interest in which R2 values were measured
roi=R2[x-1:x+1,y-1:y+1,i+1]
ave[i]=average(roi) ;average between slices
std[i]=stdev(roi) ;standard deviation between slices
print,ave[i],std[i]
Endfor
print,average(ave),average(std) ;test print
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;test plot
;For i=0,9 Do begin
;plot,ave[i],psym=4
;oploterr,std[i]
;Endfor
END
B.6 Compute 3DR2 gel
Pro Compute3DR2gel,pdfile,T2file,filename ;computes R2 values for CGEL-S vessel
openr,1,'3D/'+pdfile ;opens proton density file
img3De=intarr(256,256,70)
readu,1,img3De
close,1
openr,1,'3D/'+T2file ;open T2 file
img3Df=intarr(256,256,70)
readu,1,img3Df
close,1
;mask used to eliminate regions outside of gel region (eliminates noise)
mask=bytarr(256,256,70)
for x=0L,255 do $
for y=0L,255 do begin
temp =(x-122)^2+(y-128)^2
if (temp LE 93L^2) then mask[x,y,*]=1
endfor
case filename of ;masks according to which filename used
'28925':img3Df=img3Df*mask;28925
'28943':img3Df=img3Df*mask;.rotpd
'28943b':img3Df=img3Df*shift(mask,1,0,0);.2rotpd
'17263':img3Df=img3Df*shift(mask,1,0,0);17263
'28948':img3Df=img3Df*shift(mask,1,0,0);'28948'
endcase
;computes R2
TE2=116
TE1=21.8
R2=fltARR(256,256,70) ;variable for final R2 values
R2[*] = 0 ; initializes array
temp = fltARR(256,256,70) ; working variable during calculations
temp[*] = 0 ;initializes
indexes = Where(img3Df NE 0, count) ; excludes zero in denominator
temp[indexes] = float(img3De[indexes])/img3Df[indexes] ; proton density/T2
indexes = Where(temp GT 1, count) ; excludes negative results from ln
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R2[indexes]=(alog(temp[indexes])/(TE2-TE1))*1000 ;calculate R2 at valid points
;saves file to dose directory
openw,1,'dose/'+filename+'.R2'
writeu,1,R2
close,1
END
B.7 Dose comp
Pro DoseCompute,filename1,filename2;filename1--nosub1.R2 then nosub2.R2,filename2-sub1.R2 then sub2.R2
;program reads in R2 files and determines dose for each pixel in 256X256 matrix
openr,1,'dose/'+filename1+'.R2';read nosub1.R2 and nosub2.R2
img3D=fltarr(256,256,70)
readu,1,img3D
close,1
Dose=fltarr(256,256,70)
Dose=(img3D*100-4.6953)/.6478
openw,1,'dose/'+filename1+'.dose1'
writeu,1,dose
close,1
openr,1,'dose/'+filename2+'.R2';read in sub1.R2 and sub2.R2
img3D=fltarr(256,256,70)
readu,1,img3D
close,1
Dose=img3D*100/1.3054
openw,1,'dose/'+filename2+'.dose1'
writeu,1,dose
close,1
end
B.8 Get xy
PRO getxy,x,y, DATA = data, DEVICE = device
IF ( KEYWORD_SET( data ) EQ 0 AND KEYWORD_SET( device ) EQ 0 ) THEN device =
1
PRINT, 'Mark point with cursor'
CURSOR, x, y, DEVICE = device, DATA = data
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PRINT, x, y
END
B.9 Load CT data
Function loadCTdata ;function used to read in CT data which was later used for analysis
spawn,'ls -1 /home/paul/ctdata/new/17258.*.img',list
CT3D=intarr(512,512,54)
For i=0,53 Do begin
temp=read_dicom(list[i])
CT3D[*,*,i]=temp
ENDFOR
return, CT3D
end
B.10 Read my file
Function readmyR2file,filename ;used to read in R2 file information and used for analysis
openr,1,'R2/'+filename+'.r2'
R2=fltarr(256,256)
readu,1,R2
close,1
return,R2
end
B.11 Resize
;+
; NAME:
; resize
;
; PURPOSE:
; Resizes a 2-d array
;
; CATEGORY:
; Function
;
; CALLING SEQUENCE:
; nwarr = resize( array, MX=mx, MY=my )
;
; INPUTS:
; array 2-d array to resize
;
; OPTIONAL INPUT PARAMETERS:
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; mx new x-dimension
; my new y-dimension
; OUTPUTS:
; nwarr resized array with dimension mx x my
;
; MODIFICATION HISTORY:
; 13-Nov-92 C.E. Ordonez
; - This function implements simple linear interpolation
; to resize a 2-d array. This seems to work better than
; the user routine CONGRID.
;;-----------------------------------------------------------------------; function resize
;-----------------------------------------------------------------------FUNCTION resize, array, MX=mx, MY=my
; Are you trying to trick me?
change=0
IF keyword_set(MX) NE 0 then change=change+1
IF keyword_set(MY) NE 0 then change=change+2
IF change EQ 0 then return,array
b=size(array)
IF (b(0) NE 2 ) then BEGIN
print,'% Input is not a 2-D array'
return, 1
ENDIF
nx=b(1)
ny=b(2)
rx=1.0
ry=1.0
xresize=0
yresize=0
CASE change OF
1: BEGIN
IF (mx EQ nx) then return,array
xresize=1
rx = float(mx) / float(nx)
END
2: BEGIN
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IF (my EQ ny) then return,array
yresize=1
ry = float(my) / float(ny)
END
3: BEGIN
IF (mx NE nx) then BEGIN
xresize=1
rx = float(mx) / float(nx)
END ELSE mx = nx
IF (my NE ny) then BEGIN
yresize=1
ry = float(my) / float(ny)
END ELSE my = ny
END
ENDCASE
; Requested output dimensions same as input's
IF (xresize+yresize) EQ 0 then return,array
; Prepare for rescaling
p=fltarr(2,2)
q=fltarr(2,2)
p(0,1)=1.
q(1,0)=1.
IF xresize EQ 1 then p(0,1)=p(0,1)/rx
IF yresize EQ 1 then q(1,0)=q(1,0)/ry
tmp=poly_2d(array, p, q, 1, mx, my )
; Rescale total counts
tmp=tmp/(rx*ry)
return,tmp
end
B.12 Rots
;+
; ROTS is used by BCKROT.PRO AND FWDROT.PRO to rotate
; the image matrix during backprojection/forward-projection.
;;-----------------------------------------------------------------------; FUNCTION ROTS
;-----------------------------------------------------------------------FUNCTION rots, a, angle
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b = SIZE( a )
xc = ( b( 1 ) - 1. ) / 2.
yc = ( b( 2 ) - 1. ) / 2.
theta = -angle / !RADEG
c = COS( theta )
s = SIN( theta )
kx = -xc + c * xc - s * yc
ky = -yc + s * xc + c * yc
kk = 1. / ( 1. + ( s / c )^2 )
cx = kk * [ s / c^2 * ky + kx / c, s / c^2 , 1 / c, 0. ]
cy = kk * [ -s / c^2 * kx + ky / c, 1 / c, -s / c^2, 0. ]
RETURN, POLY_2D( a, cx, cy, 1, MISSING = 0 )
END
B.13 Save my 3D file
Pro savemy3Dfile,filename ;program reads in images and saves them as proton density and
T2 files
spawn,'ls -1 ' + filename+'.*.img',list
img3D=intarr(256,256,70)
For i=0,69 Do begin
temp=read_dicom(list[i+70])
img3D[*,*,i]=temp
ENDFOR
openw,1,'3D/'+filename+'.pd'
writeu,1,img3D
close,1
For i=0,69 Do begin
temp=read_dicom(list[i])
img3D[*,*,i]=temp
ENDFOR
openw,1,'3D/'+filename+'.T2'
writeu,1,img3D
close,1
;used to analyze effects of rebinning
;tvscl,rebin(img3D(*,*,13),512,512)
;tvscl,rebin(img3D(*,*,40),512,512)
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;tvscl,rebin(img3D(*,*,47),512,512)
end
B.14 Save my 3D rot file
Pro savemy3Drotfile,file2; file 2 is pre-irradiation
;program reads in images, rotates them relative to post-irradiaton images and saves them as
proton density and T2 files
img3Dc=intarr(256,256,70)
img3Dd=intarr(256,256,70)
img3De=intarr(256,256,70)
img3Df=intarr(256,256,70)
spawn,'ls -1 ' + file2+'.*.img',list
For i=0,69 Do begin
temp=read_dicom(list[i+70])
img3Dc[*,*,i]=temp
ENDFOR
For i=0,69 Do begin
temp=read_dicom(list[i])
img3Dd[*,*,i]=temp
ENDFOR
For i=0,69 do begin img3De[*,*,i]=rebin(shift(rebin(img3Dc(*,*,i),512,512),-3,2),256,256)
openw,1,'3D/'+file2+'.2rotpd';2 is used for subtraction from the data 2 months postirradiation
writeu,1,img3De
close,1
ENDFOR
For i=0,69 do begin img3Df[*,*,i]=rebin(shift(rebin(img3Dd(*,*,i),512,512),-3,2),256,256)
openw,1,'3D/'+file2+'.2rotT2'
writeu,1,img3Df
close,1
ENDFOR
end
B.15 Show all images
Pro showallimages,filename,position=index ;shows gel images
if (Not Keyword_set(index)) then index=0 ;!=not
filename = filename + '.*.img'
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spawn, 'ls -1 ' + filename, list
print, list
;window,xsize = 1200,ysize = 512
n = n_elements(list)
for i=0,n-1 do tvscl, rebin(read_dicom(list[i]),64,64), i+index
end
B.16 Show image
Pro showimage,filename ;shows an image
img=read_dicom(filename)
tvscl,img
end
B.17 Subtraction
Pro subtraction,postfile,prefile,filename,DOROT=dorot; sub1=5 days post, sub2=2 months
post
;performs images subtraction procedure; subtracts pre-irradiation from post-irradiaion
openr,1,'dose/'+postfile;28925.R2 for 5 days post,17263.R2 for 2 months post
postR2=fltarr(256,256,70)
readu,1,postR2
close,1
openr,1,'dose/'+prefile;28943.R2 when 28925.R2 is used, 28943b.R2 when 17263.R2 is used
preR2=fltarr(256,256,70)
readu,1,preR2
close,1
R2sub=fltarr(256,256,70)
R2sub=postR2-preR2; subtracts pre-irradiation values from post-irradiation values
Result=fltarr(256,256,70)
If keyword_set(DOROT) then $
FOR z=0,69 Do $
;next line rotates 5 days post-irradiatoin MRI image (post-pre) with respect to CT image
(determined in analysis)
result[*,*,z]=shift(ROT(R2sub[*,*,z],2.4,1,120,127,/INTERP,/pivot,missing=0),7,-3) $
else result=shift(R2sub,5,-3,0) ;no rotation for 2 months post image
openw,1,'dose/'+filename+'.R2'; saves the file to dose file under sub1 or sub2
writeu,1,result
close,1
end
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